DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TRAV19; IGKV1-12; CD300LB; NCR3; TYROBP; SH2D1A; LILRA1; NCR1; CRTAM; NCR2; CD160; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV6-57; CD8A; TRBV12-3; TRAV8-4; IGHV3-11; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-59; IGKC; TRAC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; ITGB2; IL4; IGKV2-30; IGKV4-1; IGHV4-34; CD3E; FCGR3A; CD3G; IGLC2; IGLC3; CD8B; FCGR1A; IFITM1; ICAM2; SELL; CD1D; HLA-G; LAG3; CD33; CD22; ITGAL; CD247; IGHV1-2; CD40LG; HLA-F; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; CD300C; KLRD1; MICB; CD300E; TREML2; LAIR1; LAIR2; TREML4; CD300LD; JAML; TREML1; OSCAR; LILRB2; LILRB1; CD200R1; CD300LF; SLAMF6; KIR2DL4; TREM1; KLRF1; HCST; CD300A; PILRA; ICAM5; SIGLEC9; BTN3A1; HHLA2;	GO:0050776~regulation of immune response	97	216	44.9074074074074	0	0	0	0	0	0	0
up	IGKV1-12; TNFRSF10B; DOK2; F2; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-40; IGLV2-14; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV6-57; IGHV3-11; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-59; IGKC; IGHM; FN1; IGLV7-43; IGKV1-16; IGKV3-11; GYPC; ITGB3; ITGB2; LCK; IGKV2-30; IGKV4-1; IGHV4-34; CD2; DBH; CD48; IGLC2; IGLC3; ITGAM; SELL; CD44; SELP; PECAM1; ITGAL; ITGAX; IGHV1-2; PTPN6; FCER1G; CEACAM8; L1CAM; SDC2; SIRPA; SELPLG; JAML; INPP5D; CD244; TREM1; SIRPG; CD84; VPREB3; SLC7A7;	GO:0050900~leukocyte migration	64	193	33.160621761658	0	0	0	0	0	0	0
down	E2F8; ZBTB42; CBX4; BHLHE40; OVOL1; MEIS2; ZBTB7B; FOXP2; SOX15; SORBS3; HSBP1; ZNF205; SPDEF; KLF8; IL33; TBX6; TFAP2A; ENO1; NR2F6; TXN; SCGB1A1; BMP2; BMP4; HOXD8; RARG; NR1D1; EFNA1; FGFR2; CCND1; HOXD9; SOX18; MMP12; IFI27; FRK; SOX2; HDGF; ATN1; FOXA1; C1QBP; FOXM1; FOXF1; FOXC1; TRIM28; KLF5; TRIM29; FHL2; HES1; CBX2; NFIX; HES5; MLIP; KCTD1; NRARP; IRF2BP1; BCL6B; SDR16C5; PPP1R13L; TFAP2B; TFAP2C; FOXJ1; AURKB; AJUBA; PAWR; TRIB3; MDFI; SMO; OVOL2; IRX2; FOXQ1; NKX6-2; PEG3; ANKRD2; WWTR1; TP63; TRPV4; DLL4; ZNF219; HEY2; MOSPD1; NOTCH3; ETV7; PIAS3; ID1; NFIB; HES4; HES2; ID4; RIPPLY3;	GO:0000122~negative regulation of transcription by RNA polymerase II	88	847	10.3896103896104	0	0	0	0	0	0	0
down	EI24; ALOX15B; BIRC5; CIDEA; NOL3; GJB6; PAK4; S100A8; CDK1; S100A9; CEACAM5; CGB7; RALB; GJA1; FGFR2; KRT20; LTBR; CEACAM6; IFI27; LGALS7; BCAP31; EFNA5; FAM3B; DAD1; DYNLL1; EIF5A; C1QBP; BIK; ADAM15; GAS6; DHCR24; PHLDA2; STEAP3; CIAPIN1; TRAF7; ATG4D; MRPL41; UNC5B; SLC5A8; PPP1R13L; TFAP2B; BAD; ELMO3; SFRP2; PAWR; KREMEN1; GSDMA; TRAIP; CDCA7; CARD14; PEG3; TP63; EGLN3; TP53AIP1; S100A14; PTPRH; PAK6; PAK5; GULP1; PUF60; BOK; NCKAP1; CHMP3; TMEM14A; CASP14;	GO:0006915~apoptotic process	65	552	11.7753623188406	0	0	0	0	0	0	0
down	AGPAT2; FOXN1; TGM5; KRT34; GJB5; KRT14; KRT5; DSP; KRT15; SPRR1B; SPRR2E; SPRR2D; CRABP2; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; ELF3; KRT32; KRT31; CST6; ZNF750; GRHL2; CERS3; ACER1; GRHL3; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	39	82	47.5609756097561	0	0	0	0	0	0	0
down	DAPL1; CFAP69; SRRM4; SOX15; KRT6A; TFF1; INHA; FGF1; MGP; SRD5A1; COL15A1; RBM11; KRTDAP; AAMP; CBX2; ANGPT1; INA; ODF4; ZNF750; MORN2; NXN; CXCL17; EGFL6; ACER1; EDA; ATOH8; RARRES2; PPDPF; MOSPD1; NDRG2; RFNG; SOX17; POU3F1; NKX2-8; KIAA1522; HES5; POU2F3; FOXA1; SPINK6; ETV1; FOXI2; NR1D1; ID1; HNF4A; FOXA3; SPDEF; FOXC1; HES1; CCDC160; SOX18; EGFR; NKX6-2; FOXQ1; EYA2; PTK6; SOX2; NR2F6; ETV7; FRK; SOX7; EHF; DLX5; HES2; SOX21; SPINK5; BHLHE40; HES4; ID4; ELF3; RARG; DLX3; HEY2; YES1;	GO:0030154~cell differentiation	73	572	12.7622377622378	0	0	0	0	0	0	0
down	KRT33A; KRT34; KRT14; KRT6A; KRT6B; KRT1; KRT18; KRT7; KRT16; KRT3; KRT10; KRT13; KRT5; JUP; DSP; KRT15; CASP14; SFN; DSG3; KRT9; KRT20; KRT2; KRT6C; KRT76; DSG1; DSC2; KRT17; TGM3; PKP1; DSG2; KRT32; DSC3; KRT31; LCE3E; LCE3A; KRT40; KRT80; KRT77; ABCA12; SPRR4; CNFN; KRTAP3-2; PKP3;	GO:0031424~keratinization	43	181	23.7569060773481	0	0	0	0	0	0	0
down	AKR1B15; PIR; SCD; HR; AKR1B10; ALOX12B; CBR3; BBOX1; TM7SF2; CYP11A1; CYP2E1; LIPF; P4HB; UQCRH; GSTA1; SOD3; TXN; MGST1; G6PD; CYP2C9; BMP2; CYP4B1; NQO1; CBR1; POR; AOC1; MAOA; GPX3; FDXR; ACADL; ALDH3A1; FMO3; UQCRC1; PRDX2; PYCR1; CYP2C19; SPR; ADH7; ALDH1A3; ALDH3B2; TDO2; ALDH7A1; PGD; AKR1C2; BDH1; PRDX1; PRDX4; PTGR1; DHCR24; NSDHL; MSMO1; TP53I3; PHYHD1; CYB5R2; NXN; CYP4F22; DEGS2; PAOX; MOXD1; DHRS11; FA2H; LDHD; CYP4X1; CYP4Z2P; SDR16C5; PTGR2; FADS6; SDR9C7; HSD17B8; DIO2; HGD; COX4I2; DHRS1; RDH12; HSD17B10; TXN2; HEPH; TXNDC17; DOHH; ALOXE3; HSD3B7; EGLN3; L2HGDH; CYP4F12; CYP26B1; DUOX2; DUOX1; PNPO; CYP39A1; TECR; STEAP1; PCYOX1; HIGD1A; CYP2J2; CYP2F1; CYP2C18; STEAP3;	GO:0055114~oxidation-reduction process	97	526	18.4410646387833	0	0	0	0	0	0	0
up	CYBB; CYBA; NCF1; NCF2; CD52; SLC11A1; NCF4; NCF1B; NCF1C;	GO:0045730~respiratory burst	9	13	69.2307692307692	0.00010197635159969	0.0148621090201781	0.398625558403217	0.401276943544809	0.39760579488722	0.398625558403217	0.131604107426105
down	UQCRQ; UQCRH; CYC1; UQCRC1; UQCRFS1; UQCC3;	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c	6	15	40	0.00010493092287644	0.00329052611994595	0.49705778166572	0.513322074711569	0.34414729295692	0.49705778166572	0.029853871978799
down	YES1; SLC2A1; OCLN; FFAR4; TRIB3;	GO:0010827~regulation of glucose transmembrane transport	5	9	55.5555555555556	0.00012430564844756	0.00382454863022318	0.588587245399219	0.608103232205486	0.374781530069407	0.588462939750771	0.0346988843186114
down	PLTP; ABCA12; CPTP; GLTPD2; GLTP;	GO:0035627~ceramide transport	5	9	55.5555555555556	0.00012430564844756	0.00382454863022318	0.588587245399219	0.608103232205486	0.374781530069407	0.588462939750771	0.0346988843186114
down	MB; ME1; FHL2; DHCR24; RERG; TXN2; PIAS3; TIMP2; POR;	GO:0009725~response to hormone	9	42	21.4285714285714	0.00012615330196341	0.00383317983357164	0.59708357819285	0.617141953205033	0.377702986078469	0.596957424890887	0.0347771924159779
down	ALOX15B; NUPR1; GMNN; INHA; BMP2; BMP4; BMP7; RNF167; CHMP1A;	GO:0045786~negative regulation of cell cycle	9	42	21.4285714285714	0.00012615330196341	0.00383317983357164	0.59708357819285	0.617141953205033	0.377702986078469	0.596957424890887	0.0347771924159779
down	ZNF205; MT-CO2; DUOXA1; DUOXA2;	GO:0010729~positive regulation of hydrogen peroxide biosynthetic process	4	4	100	0.00013395165402574	0.00399707794912972	0.633591323541767	0.655291491493937	0.390067216522965	0.633591323541767	0.0362641866476231
down	CETN3; YKT6; CHP2; SNX3; RAMP2; RAMP3; MYO1D; YIF1A; KIF20A; KDELR2; RAB38; VAMP2; DUOXA1; DUOXA2; GOLT1A; ATG4D; CADPS2; SNX21; RHBDF1; CHMP4C; MVB12A; GORASP1; VAMP8; MYO5B; SNX7; SCAMP4; CHMP1A; CHMP3;	GO:0015031~protein transport	28	310	9.03225806451613	0.00013399852486861	0.00399707794912972	0.63367902410369	0.655520783657275	0.390074831565137	0.63367902410369	0.0362641866476231
down	SRRM4; KALRN; GJB1; NTF3; PTN; ACHE; EFNA5; DLX5; VLDLR; PCDH1; HES1; EFNB3; RAPGEF5; FGF14; ATOH8; NDN; NRTN; SDCBP2; NRN1; RAPGEFL1; INTU; GDA; RFNG; ERBB3; NAV2; ROR1; RBFOX2;	GO:0007399~nervous system development	27	294	9.18367346938776	0.00013627709664354	0.00401606961915795	0.644181835834035	0.66666755678022	0.3937045322032	0.644181835834035	0.0364364918854541
down	INHA; BMP4; BMP7; CDKN2B; CDKN2C; DYNLL1;	GO:0042326~negative regulation of phosphorylation	6	16	37.5	0.00013959521825257	0.0040892204053389	0.65972700146167	0.682899807691597	0.398305900700878	0.65972700146167	0.0371001651480844
down	AOC1; GJB2; ID1; SLC1A3; HYAL1; HYAL2; ENDOG;	GO:0046677~response to antibiotic	7	24	29.1666666666667	0.00014223100569177	0.00414163142764377	0.672041501893628	0.695794079844154	0.40190034416585	0.672041501893628	0.037575673286641
down	YAP1; CX3CL1; HES5; DLL4; HEY2; HES1; BHLHE40; HES2;	GO:0050767~regulation of neurogenesis	8	33	24.2424242424242	0.00014348518781492	0.00415342922361321	0.677824027237725	0.701929538790633	0.403616089969408	0.677824027237725	0.0376827108477072
down	CDH1; JUP; DSP; CDH5; EFNB2; CDH17; NECTIN1; NECTIN2; NECTIN4;	GO:0034332~adherens junction organization	9	43	20.9302325581395	0.00014739101967964	0.00424139334278127	0.696127785946956	0.721036868272816	0.408862688591331	0.696127785946956	0.0384807806568033
up	ACOD1; KCNN4; LILRA1; LILRB3; OR2H2; HP; MPO; INHBA; CD48; GATA3; IL32; WAS; LILRA2; IL31RA; NLRP3; CSF3R; CLEC1B; CD84; STAT5A; CYBB; STAT5B;	GO:0006952~defense response	21	72	29.1666666666667	0.00015055975999733	0.0211590234139115	0.588387542069595	0.592452655589523	0.585978585909637	0.588387542069595	0.187363340331796
down	TP73; BIRC5; LRP5; CXCL10; NME1; GJA1; NTF3; PRDX2; TNFSF9; BCAR1; CARD18; TP53I3; TNFAIP8L3; STEAP3; DYNAP; RABGGTA; AKT1S1; PERP; TP63; TP53AIP1; CIDEA;	GO:0042981~regulation of apoptotic process	21	202	10.3960396039604	0.0001572018773237	0.00449726072437185	0.742307264722556	0.769031583867586	0.421867223614529	0.742307264722556	0.0408021820908333
down	ADCY6; AQP1; RAB11A; ADCY2; TFAP2B; AQP3; CYP4F12; MYO5B;	GO:0003091~renal water homeostasis	8	34	23.5294117647059	0.00017131037701911	0.00476164979759958	0.8082423587762	0.838050364377526	0.438211944414904	0.808071048399181	0.0432008980581339
down	OVOL1; GJB3; RYR1; KRT9; DHCR24; SLC27A4; TFAP2B; DSP;	GO:0043588~skin development	8	34	23.5294117647059	0.00017131037701911	0.00476164979759958	0.8082423587762	0.838050364377526	0.438211944414904	0.808071048399181	0.0432008980581339
down	LMNA; CDK1; CCNB1; FHL2; HEY2;	GO:0055015~ventricular cardiac muscle cell development	5	10	50	0.00018055630081381	0.00496225518865838	0.851503514637959	0.883281423581191	0.447418513416638	0.851322958337146	0.0450209254472569
down	PDLIM4; PDLIM3; PRICKLE4; PDLIM2; PDLIM1;	GO:0061061~muscle structure development	5	10	50	0.00018055630081381	0.00496225518865838	0.851503514637959	0.883281423581191	0.447418513416638	0.851322958337146	0.0450209254472569
down	SLC9A3R1; CA2; KRT6A; KRT16; SERPINB5; RIPK4;	GO:0002009~morphogenesis of an epithelium	6	17	35.2941176470588	0.00018273639491051	0.00499411421174421	0.861419365608143	0.893946443902214	0.449548235690136	0.861419365608143	0.0453099719893308
down	RHOD; MYO1B; SHROOM2; PAWR; CORO1B; BAIAP2; AIF1L; PLS3; PLS1;	GO:0051017~actin filament bundle assembly	9	45	20	0.00019887071437307	0.00540486408173944	0.937277676840318	0.972875534713099	0.465556342347376	0.937277676840318	0.0490365718056383
down	MATN2; DVL1; BMP7; GPC1; ETV1; EPHB3; VLDLR; GRB7; NECTIN1; DOK4; NRTN; VSTM2L; EFNA3; EFNA5; IGSF9; EFNB2; UNC5B; ROBO4; EFNA1; EFNB3; PALLD;	GO:0007411~axon guidance	21	206	10.1941747572816	0.00020102522929155	0.00543323437400149	0.947230880421791	0.98341542169427	0.467641197245579	0.947230880421791	0.0492939662289977
down	PLA2G2A; PLA2G4A; PLA2G4E; LPCAT4; PLA2G4F; MBOAT2; PLA2G2F;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	7	26	26.9230769230769	0.00021606061723034	0.00577578436880232	1	1	0.481610691215555	0.999999349769181	0.0524018107858706
down	ZBTB7B; KALRN; MT-CO2; GOT2; NME1; PRLR; CCND1; XDH; DDR1;	GO:0007595~lactation	9	46	19.5652173913043	0.00022973841839601	0.00591515969891225	1	1	0.491640215367481	0.999999349769181	0.0536663177705995
down	GJB6; CXCL14; C1QB; BMP2; GJB2; SOX2; HOXA1; ROR1; CYTL1;	GO:0048839~inner ear development	9	46	19.5652173913043	0.00022973841839601	0.00591515969891225	1	1	0.491640215367481	0.999999349769181	0.0536663177705995
down	DEFB4A; CXCL10; SAA1; SAA2; BMP4; NTF3; CX3CL1; GPNMB; ANGPT1;	GO:0050918~positive chemotaxis	9	46	19.5652173913043	0.00022973841839601	0.00591515969891225	1	1	0.491640215367481	0.999999349769181	0.0536663177705995
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00023375864470032	0.00595773532831434	1	1	0.4945781757091	0.999999349769181	0.0540525925920885
down	CFAP69; OVOL1; CTSV; GJB3; PTTG1; CCNB1; GJA1; TSPAN8; SSTR1; KRT9; BCAP31; HSPA2; FOXA3; PRDX4; WFDC2; TRIP13; ODF4; MORN2; SHISA6; POC1A; CREB3L4; BCL2L2; BAD; FOXJ1; KIFC1; LGR4; TP63; SOX17; ELL3; BCL2L10; CYP26B1; DUSP13; GGT5;	GO:0007283~spermatogenesis	33	407	8.10810810810811	0.00023382771525681	0.00595773532831434	1	1	0.4945781757091	0.999999349769181	0.0540525925920885
down	ALOX15B; MT1A; MT1G; MT1X; PTK6; MT1M;	GO:0045926~negative regulation of growth	6	18	33.3333333333333	0.00023574945734083	0.00597557691871184	1	1	0.496016858245126	0.999999349769181	0.054214463531935
down	GAS8; POR; FOXA1; IHH; TTC23; ULK3; INTU; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	8	36	22.2222222222222	0.000240309227576	0.00599792214949913	1	1	0.499362574902944	0.999999349769181	0.0544171945344992
down	DSP; ITGB5; IHH; PLEKHA7; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	5	11	45.4545454545455	0.00025432238727607	0.00628356120482097	1	1	0.508337317523385	0.999999349769181	0.0570087046696211
down	JUP; DSP; DSC2; DSG2; TRPM4;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.00025432238727607	0.00628356120482097	1	1	0.508337317523385	0.999999349769181	0.0570087046696211
down	ALOX15B; ALOX12B; ALOX12; PLA2G4A; MGLL; ALOXE3; CYP4F12;	GO:0019369~arachidonic acid metabolic process	7	27	25.9259259259259	0.00026309961903825	0.00643541668167569	1	1	0.513816722957525	0.999999349769181	0.0583864399618044
up	CCL5; CXCR2; CCR1; CXCR5; CCR2; CCR10; CX3CR1; CXCR3; CCR3; CCR5; CCR6; CMKLR1; CCL26; CCL2; PPBP; CCL4; CCL3; CXCL5; CCL24; CCL7;	GO:0070098~chemokine-mediated signaling pathway	20	70	28.5714285714286	0.00026850571096592	0.0343145797159142	1	1	0.929430022615719	1	0.30385590827544
up	ACOD1; TLR4; KMO; SERPINE1; CD14; VIM; CSF3; RARA; CCL2; CD36; TNFRSF1B; TBXA2R; IL10; TNFSF4; CASP1; CX3CR1; CCR5; SIRPA; IRF8; CARD16; LILRB2; LILRB1; NLRP7; TNIP3; NLRP3; GFI1; STAP1; PDCD1LG2; LY96; CD80; CD86; DEFA3; CXCL5; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	35	163	21.4723926380368	0.00027033086942651	0.0343145797159142	1	1	0.933097282098927	1	0.30385590827544
down	FOXN1; FZD6; EGFR; SOX18; NSDHL; APCDD1; LGR4; SOX21;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.00028249534328406	0.006807720292343	1	1	0.525854994193818	0.999999349769181	0.0617642293866423
down	SPTLC1; ALOX12B; PSAPL1; ACER1; ALOXE3; TECR;	GO:0006665~sphingolipid metabolic process	6	19	31.5789473684211	0.00030014796965394	0.0070254730504645	1	1	0.536870353875002	0.999999349769181	0.0637398292533579
down	MYO5B; MYO5C; MYO1D; MYO1B; MYO1E; MYO1C;	GO:0030050~vesicle transport along actin filament	6	19	31.5789473684211	0.00030014796965394	0.0070254730504645	1	1	0.536870353875002	0.999999349769181	0.0637398292533579
up	MEFV; THBS1; IL10; ARRB2; JAK3; SLAMF1; TIGIT; CMKLR1;	GO:0032695~negative regulation of interleukin-12 production	8	12	66.6666666666667	0.00030048475274324	0.0369502344388961	1	1	0.982262938502943	1	0.327194654265696
down	RHOD; ERBB2; P4HB; SAA1; C1QBP; HYAL1; ANGPT1; EPB41L4B; ADGRG1;	GO:0045785~positive regulation of cell adhesion	9	48	18.75	0.00030345477625493	0.00703554865137023	1	1	0.538935682628756	0.999999349769181	0.0638312418994165
down	NDUFS4; EGFR; S100A6; ANXA2; CCNB1; PDGFRA; AQP1; BTC; GAS6;	GO:0048146~positive regulation of fibroblast proliferation	9	48	18.75	0.00030345477625493	0.00703554865137023	1	1	0.538935682628756	0.999999349769181	0.0638312418994165
up	TYROBP; CTLA4; IL10; MNDA; BTK; PKN1; INPP5D; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	9	16	56.25	0.00032132712232013	0.038315825040295	1	1	1	1	0.339286971174594
down	HFE; CHST9; DIO2; DUOX2; DUOX1;	GO:0042446~hormone biosynthetic process	5	12	41.6666666666667	0.00034890815889376	0.00782962712526749	1	1	0.567253574010935	0.999999349769181	0.0710356573140671
down	RAMP2; CEACAM1; CD34; KDR; TMEM100;	GO:2001214~positive regulation of vasculogenesis	5	12	41.6666666666667	0.00034890815889376	0.00782962712526749	1	1	0.567253574010935	0.999999349769181	0.0710356573140671
down	MT-CO2; COX6C; COX8A; COX5B; COX7B; COX4I2;	GO:0006123~mitochondrial electron transport, cytochrome c to oxygen	6	20	30	0.00037756221314655	0.00814033978487742	1	1	0.581607205029806	0.999999349769181	0.0738546520960746
down	EDN3; AVPR1A; SLC1A1; NMU; TRPM4; HEY2;	GO:0010460~positive regulation of heart rate	6	20	30	0.00037756221314655	0.00814033978487742	1	1	0.581607205029806	0.999999349769181	0.0738546520960746
down	TBX6; PDGFRA; EPCAM; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	6	20	30	0.00037756221314655	0.00814033978487742	1	1	0.581607205029806	0.999999349769181	0.0738546520960746
down	GJA1; CD34; GJA4; KDR;	GO:0003158~endothelium development	4	6	66.6666666666667	0.00037773040293687	0.00814033978487742	1	1	0.581704820522781	0.999999349769181	0.0738546520960746
down	ALOX15B; ALOX12B; ALOX12; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	4	6	66.6666666666667	0.00037773040293687	0.00814033978487742	1	1	0.581704820522781	0.999999349769181	0.0738546520960746
down	JUP; DSP; DSC2; DSG2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00037773040293687	0.00814033978487742	1	1	0.581704820522781	0.999999349769181	0.0738546520960746
down	OVOL1; FBLN1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	4	6	66.6666666666667	0.00037773040293687	0.00814033978487742	1	1	0.581704820522781	0.999999349769181	0.0738546520960746
down	MT1G; AOC1; AQP1; MAP1LC3A; MT1X; MT1A; MT1M;	GO:0071280~cellular response to copper ion	7	29	24.1379310344828	0.00038178781898567	0.00815592144313512	1	1	0.583371787410118	0.999999349769181	0.0739960194075277
up	CR1; C3AR1; FPR3; FPR1; CMKLR1; FPR2; C5AR1; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	8	13	61.5384615384615	0.00044488291228694	0.0478568201631643	1	1	1	1	0.423772567761006
down	MYO1C; CCL21; CCL11; CTTN; CDC42EP5; NCKAP1; BAIAP2; CDC42EP1; CDC42EP4;	GO:0030838~positive regulation of actin filament polymerization	9	51	17.6470588235294	0.00044982763563472	0.00943919541430596	1	1	0.61211847535202	0.999999349769181	0.085638746270212
up	CCL5; CXCR2; CCR1; CCR7; GPR183; CCR2; PIK3CG; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	9	17	52.9411764705882	0.00044998788971717	0.0478568201631643	1	1	1	1	0.423772567761006
up	ADA; CD4; CD3E; CCL3; CCL4; ZAP70; TRAT1; P2RX5; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	9	17	52.9411764705882	0.00044998788971717	0.0478568201631643	1	1	1	1	0.423772567761006
up	TLR4; FCN1; FFAR2; TLR2; CD2; CD14; F2R; TLR1; CD244;	GO:2000484~positive regulation of interleukin-8 secretion	9	17	52.9411764705882	0.00044998788971717	0.0478568201631643	1	1	1	1	0.423772567761006
down	UNC13B; GIPC1; PPFIA3; GJA1; SLC1A3; SLC1A1; VAMP2;	GO:0014047~glutamate secretion	7	30	23.3333333333333	0.00045536592759121	0.00943919541430596	1	1	0.613838364970571	0.999999349769181	0.085638746270212
down	RAMP2; PAK4; KDR; TEK; GAS6; ANGPT1; NDNF;	GO:2000352~negative regulation of endothelial cell apoptotic process	7	30	23.3333333333333	0.00045536592759121	0.00943919541430596	1	1	0.613838364970571	0.999999349769181	0.085638746270212
down	CLDN5; RAMP2; DDAH1; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	5	13	38.4615384615385	0.00046785733467347	0.00953506575384958	1	1	0.618012770426652	0.999999349769181	0.0865085466422407
down	CYP2F1; CYP2J2; CYP2C19; CYP2E1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	6	21	28.5714285714286	0.00046973647724402	0.00953506575384958	1	1	0.618628370366333	0.999999349769181	0.0865085466422407
down	PLA2G2A; PLA2G4A; PLA2G4E; LPCAT4; PLA2G4F; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	6	21	28.5714285714286	0.00046973647724402	0.00953506575384958	1	1	0.618628370366333	0.999999349769181	0.0865085466422407
down	CLDN1; CXADR; TJP1; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	6	21	28.5714285714286	0.00046973647724402	0.00953506575384958	1	1	0.618628370366333	0.999999349769181	0.0865085466422407
down	PLCD1; HES1; NSDHL; PLCD3; OVOL2; HEY2;	GO:0060716~labyrinthine layer blood vessel development	6	21	28.5714285714286	0.00046973647724402	0.00953506575384958	1	1	0.618628370366333	0.999999349769181	0.0865085466422407
down	ARHGAP32; RGS12; RGS5; KALRN; ARHGEF15; RASAL1; RAPGEF3; HRAS; ERBB2; CCL11; ARHGDIA; WNT4; S100A10; ARHGAP8; LLGL2; PREX2; ARHGEF19; GRHL3; USP6NL; PGAM5; CCL19; ARHGEF12; ARHGAP23; FZD10; CCL21; CX3CL1; CCL17;	GO:0043547~positive regulation of GTPase activity	27	322	8.38509316770186	0.00051329247766285	0.0103334436243896	1	1	0.631430215095926	0.999999349769181	0.0937519690826009
down	PLD2; AGPAT2; PLA2G2A; PLA2G4A; PLD1; LPCAT4; LIPI; PLA2G2F;	GO:0006654~phosphatidic acid biosynthetic process	8	41	19.5121951219512	0.00051595676197946	0.0103445101623096	1	1	0.632070737593231	0.999999349769181	0.0938523721775069
down	MEIS2; CCNB1; FOXA1; EIF4EBP1; LGMN; SMOC2; POLDIP2;	GO:0045931~positive regulation of mitotic cell cycle	7	31	22.5806451612903	0.00053982135239116	0.0107788002281534	1	1	0.638002098964215	0.999999349769181	0.0977925445252589
down	BMP2; BMP4; APCDD1; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	4	7	57.1428571428571	0.00057552028974983	0.0113985637953691	1	1	0.646727990971824	0.999999349769181	0.103415457554463
down	SPRY1; BMP4; FGFR2; YAP1;	GO:0060449~bud elongation involved in lung branching	4	7	57.1428571428571	0.00057552028974983	0.0113985637953691	1	1	0.646727990971824	0.999999349769181	0.103415457554463
down	KRT18; KRT16; KRT3; KRT6C; FAM83H; DSP;	GO:0045104~intermediate filament cytoskeleton organization	6	22	27.2727272727273	0.00057852554121551	0.0114118828533318	1	1	0.647372417439696	0.999999349769181	0.103536297030219
down	CLDN4; RAMP2; PTN; GJB2; YAP1; DSG1; DSG2; BAD;	GO:0032570~response to progesterone	8	42	19.047619047619	0.0005937515192903	0.0115263191760642	1	1	0.651195295931766	0.999999349769181	0.104574540522003
down	TSPAN15; EGFR; BMP7; NRARP; SLC35C1; DLL4; HEY2; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	8	42	19.047619047619	0.0005937515192903	0.0115263191760642	1	1	0.651195295931766	0.999999349769181	0.104574540522003
down	AGR2; EGFR; EPHB3; SFRP2; STRA6;	GO:0048546~digestive tract morphogenesis	5	14	35.7142857142857	0.00061493126166578	0.0117509520783946	1	1	0.656320000973568	0.999999349769181	0.106612561696716
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.00061493126166578	0.0117509520783946	1	1	0.656320000973568	0.999999349769181	0.106612561696716
down	MYO1C; CLDN5; GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	5	14	35.7142857142857	0.00061493126166578	0.0117509520783946	1	1	0.656320000973568	0.999999349769181	0.106612561696716
down	PSMD3; ICMT; APOE; P4HB; BMP4; IGFBP4; PSMB6; PSMB5; CCNF; PSMD8; RAB13; RAB38; UBE2M; RAB11A; KEAP1; GAS6; SPARCL1; FBXW9; AMTN; FBXO27; RABGGTA; ANKRD9; FBXO17; EPAS1; RAB1B; WSB2; KLHL13; FBXL7;	GO:0043687~post-translational protein modification	28	344	8.13953488372093	0.00062898121732391	0.0119716800236015	1	1	0.659801296972781	0.999999349769181	0.108615154467036
down	FGF1; ADRA2A; TXN; ADRA2C; NTF3; GAS6; DYNAP;	GO:0032148~activation of protein kinase B activity	7	32	21.875	0.00063627081073924	0.0119716800236015	1	1	0.661622753672646	0.999999349769181	0.108615154467036
down	TSPAN12; KRT1; ERBB2; EFNA1; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	7	32	21.875	0.00063627081073924	0.0119716800236015	1	1	0.661622753672646	0.999999349769181	0.108615154467036
down	TFAP2A; BMP4; PDGFRA; FGFR2; EIF4A3; IRX5; GRHL2;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.00063627081073924	0.0119716800236015	1	1	0.661622753672646	0.999999349769181	0.108615154467036
up	CD4; CD3E; PTPRC; CD80; CD86; STAT5B; IRF4; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	8	14	57.1428571428571	0.0006408295184207	0.0626103827620276	1	1	1	1	0.554415495661914
down	CCL21; DEFB4A; CNIH1; CXCL14; IGHA1; C1QC; SLPI; HLA-DQB2; CD1A; CD1E; IL1RN; ENDOU; FCGR2B; LTBR; TNFSF9; DEFB1; CX3CL1; MS4A2; C1QBP; NECTIN1; GBP6; EDA; CCL19; IL36B; CXCR1; ACKR2; ULBP2; CXCL10; RAET1G; RAET1L; CXCL9; RAET1E; CXCL11;	GO:0006955~immune response	33	433	7.62124711316397	0.00064089849096882	0.0120125494935612	1	1	0.662689039661762	0.999999349769181	0.108985949859487
up	PIK3CD; ITGB2; CCL3; C5AR1; CXCR2; PIK3CG; NCKAP1L; TGFB2; JAML; PREX1; CSF3R; CCL4; PPBP; FCER1G; CCL5; CXCL5; CCL26; CCL24; CCL7; CCL2;	GO:0030593~neutrophil chemotaxis	20	76	26.3157894736842	0.00065235722827017	0.0626103827620276	1	1	1	1	0.554415495661914
down	MMP7; COL15A1; MMP12; MMP15; ADAM15; KLK6; MRC2; MMP28;	GO:0030574~collagen catabolic process	8	43	18.6046511627907	0.00068074653654592	0.0125195941984311	1	1	0.672531069597935	0.999999349769181	0.113586201355732
down	SCGB1A1; IDO1; GPNMB; IL20RB; FOXJ1; PAWR; PLA2G2F; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	8	43	18.6046511627907	0.00068074653654592	0.0125195941984311	1	1	0.672531069597935	0.999999349769181	0.113586201355732
down	FOXP2; LRP5; FGFR2; FOXF1; IHH; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.00070589040570667	0.012837233697833	1	1	0.678578566920532	0.999999349769181	0.116468041099556
down	PRMT5; TP73; PTN; PTPRZ1; ZNF365; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	6	23	26.0869565217391	0.00070589040570667	0.012837233697833	1	1	0.678578566920532	0.999999349769181	0.116468041099556
down	APOE; HOXA1; FOXC1; HES1; STRA6; NOTCH3;	GO:0048844~artery morphogenesis	6	23	26.0869565217391	0.00070589040570667	0.012837233697833	1	1	0.678578566920532	0.999999349769181	0.116468041099556
down	BMP4; SDC1; FGFR2; AQP1; AQP5; PAX9; AQP3;	GO:0042476~odontogenesis	7	33	21.2121212121212	0.00074589056130103	0.0134645631951463	1	1	0.687364477677751	0.999999349769181	0.122159597348812
down	EYA2; ERBB3; LCN2; BAD; BCL2L10; BCL2L2; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	7	33	21.2121212121212	0.00074589056130103	0.0134645631951463	1	1	0.687364477677751	0.999999349769181	0.122159597348812
down	SULT2B1; CYP2E1; CYP2C9; CYP2C19; AKR1C2; MSMO1; UGT1A8; DHCR24;	GO:0008202~steroid metabolic process	8	44	18.1818181818182	0.00077772026700273	0.0138901361323947	1	1	0.693498997961953	0.999999349769181	0.126020682027412
down	NDUFS4; NME1; SDC1; AGXT; ALDH3A1; TEK; DUOX2; DUOX1;	GO:0051591~response to cAMP	8	44	18.1818181818182	0.00077772026700273	0.0138901361323947	1	1	0.693498997961953	0.999999349769181	0.126020682027412
down	OPLAH; GGCT; GGT5; GGT6; MGST2;	GO:0006750~glutathione biosynthetic process	5	15	33.3333333333333	0.000794085686036	0.0139235382655489	1	1	0.696545392388802	0.999999349769181	0.126323728704646
down	SHISA9; UNC13B; SYNGR1; PPFIA3; SHISA6;	GO:0048172~regulation of short-term neuronal synaptic plasticity	5	15	33.3333333333333	0.000794085686036	0.0139235382655489	1	1	0.696545392388802	0.999999349769181	0.126323728704646
down	TEK; FHL2; OVOL2; HEY2; ADGRG6;	GO:0060347~heart trabecula formation	5	15	33.3333333333333	0.000794085686036	0.0139235382655489	1	1	0.696545392388802	0.999999349769181	0.126323728704646
down	TUSC3; NIPAL1; ZDHHC13; NIPAL2; CLDN16;	GO:1903830~magnesium ion transmembrane transport	5	15	33.3333333333333	0.000794085686036	0.0139235382655489	1	1	0.696545392388802	0.999999349769181	0.126323728704646
down	YAP1; HES1; HES5; NELFB; TRIM6;	GO:2000737~negative regulation of stem cell differentiation	5	15	33.3333333333333	0.000794085686036	0.0139235382655489	1	1	0.696545392388802	0.999999349769181	0.126323728704646
down	GOT2; GOT1; MDH2; MDH1B;	GO:0006107~oxaloacetate metabolic process	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	LIPF; MDH2; ME1; MDH1B;	GO:0006108~malate metabolic process	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	CEACAM1; PTN; EMP2; RHOJ;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	MAOA; COMT; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	SULT2B1; BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	GOT2; AGXT; ALDH4A1; HOGA1;	GO:0046487~glyoxylate metabolic process	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	BMP2; BMP7; FGFR2; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	BMP4; FOLR1; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	PTPRF; ADAM15; HFE; CRTAC1;	GO:1900121~negative regulation of receptor binding	4	8	50	0.00083705619446128	0.0140717488086069	1	1	0.7048013157364	0.999999349769181	0.127668394699406
down	CXCL14; CXCL10; BMP4; SOSTDC1; CCL17; ANKRD2;	GO:0045662~negative regulation of myoblast differentiation	6	24	25	0.00085389333877339	0.0142354590855619	1	1	0.708005183336194	0.999999349769181	0.129153684732573
down	PLA2G2A; BDKRB2; PLA2G4A; PLA2G4F; PLA2G2F; ANXA1;	GO:0050482~arachidonic acid secretion	6	24	25	0.00085389333877339	0.0142354590855619	1	1	0.708005183336194	0.999999349769181	0.129153684732573
down	DVL1; KALRN; ERBB2; CACNB3; PPFIBP2; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	7	34	20.5882352941176	0.00086991519701051	0.0143771119722144	1	1	0.711144726702772	0.999999349769181	0.130438855246162
down	NOL3; LMNA; GSTP1; BMP4; YAP1; CTTN; PAK5;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	7	34	20.5882352941176	0.00086991519701051	0.0143771119722144	1	1	0.711144726702772	0.999999349769181	0.130438855246162
down	PIR; DVL1; MEIS2; ZBTB7B; FOXN1; NKX2-8; PTTG1; PAX1; POLR2I; ETV1; POLR2L; ELF3; KLF5; TRIM29; NFIX; TRIP13; NELFB; TFAP2B; EPAS1; ELL3; EHF; GTF2IRD1; ETV7;	GO:0006366~transcription by RNA polymerase II	23	266	8.64661654135338	0.00087713579794801	0.0144476374530696	1	1	0.712488680452018	0.999999349769181	0.131078709968462
down	CDH16; DSG1; CDH17; AJUBA; CDH22; PCDHGB4; CDH1; CDH5;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	8	45	17.7777777777778	0.00088548753709583	0.0145362584948752	1	1	0.714130270787683	0.999999349769181	0.131882739822731
up	TESPA1; RAB29; KCNN4; ADA; LCK; CCR7; TRAT1; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	8	15	53.3333333333333	0.00090081752430526	0.0843980228128861	1	1	1	1	0.747345241899244
down	RAB25; IHH; GRHL2; POF1B; PALLD;	GO:0003382~epithelial cell morphogenesis	5	16	31.25	0.00100944654952606	0.0162977310900379	1	1	0.73735526357665	0.999999349769181	0.147864007083121
down	TP73; CYP2E1; MGST1; CCND1; MGST2;	GO:0010243~response to organonitrogen compound	5	16	31.25	0.00100944654952606	0.0162977310900379	1	1	0.73735526357665	0.999999349769181	0.147864007083121
down	PMVK; CYB5R2; EBP; MSMO1; TM7SF2;	GO:0016126~sterol biosynthetic process	5	16	31.25	0.00100944654952606	0.0162977310900379	1	1	0.73735526357665	0.999999349769181	0.147864007083121
down	SAA1; KRT20; RHBDF1; RHBDD3; LLGL2;	GO:0050708~regulation of protein secretion	5	16	31.25	0.00100944654952606	0.0162977310900379	1	1	0.73735526357665	0.999999349769181	0.147864007083121
down	IL20RB; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00102469229868873	0.0163438416707877	1	1	0.739292973094561	0.999999349769181	0.148282353367088
down	GOT2; OAT; GOT1; PYCR1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	6	25	24	0.00102469229868873	0.0163438416707877	1	1	0.739292973094561	0.999999349769181	0.148282353367088
up	TNFSF4; IGHV1-69-2; IGLC3; IGHV2-70; IGHD; IGHV4-59; IGHM; IGHG1; IGHV1-2; TRBC1; IGHV1-18; IGHV3-74; IGHV3-11; TRBC2; IGLC2; IGHV4-34; IGHV3-7; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	23	98	23.469387755102	0.00103476917943013	0.0946934121176176	1	1	1	1	0.83851100566897
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00103568906744567	0.0163438416707877	1	1	0.740617677733858	0.999999349769181	0.148282353367088
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00103568906744567	0.0163438416707877	1	1	0.740617677733858	0.999999349769181	0.148282353367088
down	TMEM79; DUOX2; DUOX1;	GO:0042335~cuticle development	3	3	100	0.00103568906744567	0.0163438416707877	1	1	0.740617677733858	0.999999349769181	0.148282353367088
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.00103568906744567	0.0163438416707877	1	1	0.740617677733858	0.999999349769181	0.148282353367088
down	HES1; HES5; LGR4;	GO:0072282~metanephric nephron tubule morphogenesis	3	3	100	0.00103568906744567	0.0163438416707877	1	1	0.740617677733858	0.999999349769181	0.148282353367088
up	CD36; IGHV3-11; IGHV3-74; IGHG1; IGHV3-30; IGHV1-2; IGHV3-43; TRDC; TRBC2; IGHV3-35; IGHV1-18; IGHV1-69-2; IGLC3; IGHV2-70; IGHV3-7; IGHM; IGHV2-5; IGHD; TRBC1; IGLC2; IGKC; IGHV4-59; IGHV4-34;	GO:0006910~phagocytosis, recognition	23	99	23.2323232323232	0.00116178692620461	0.103900717150344	1	1	1	1	0.920041773542273
down	CXCL10; EDN3; ELN; PLN; BDKRB2; AVPR1A; DLL4;	GO:0008015~blood circulation	7	36	19.4444444444444	0.00116639999971968	0.0179231125878496	1	1	0.757195482445516	0.999999349769181	0.162610564133146
down	TFAP2A; SIK1; HES5; LTBP4; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	7	36	19.4444444444444	0.00116639999971968	0.0179231125878496	1	1	0.757195482445516	0.999999349769181	0.162610564133146
down	YAP1; HES1; MESP1; SOX17;	GO:0003143~embryonic heart tube morphogenesis	4	9	44.4444444444444	0.00117240311286015	0.0179231125878496	1	1	0.758049007530758	0.999999349769181	0.162610564133146
down	SFN; KRT2; KDF1; PALLD;	GO:0003334~keratinocyte development	4	9	44.4444444444444	0.00117240311286015	0.0179231125878496	1	1	0.758049007530758	0.999999349769181	0.162610564133146
down	AKR7A3; AKR1A1; ALDH3A1; ALDH7A1;	GO:0006081~cellular aldehyde metabolic process	4	9	44.4444444444444	0.00117240311286015	0.0179231125878496	1	1	0.758049007530758	0.999999349769181	0.162610564133146
down	G6PD; TP53I3; IDH1; IDH2;	GO:0006739~NADP metabolic process	4	9	44.4444444444444	0.00117240311286015	0.0179231125878496	1	1	0.758049007530758	0.999999349769181	0.162610564133146
down	KCNK1; KCNK5; TREM2; KCNK6;	GO:0060075~regulation of resting membrane potential	4	9	44.4444444444444	0.00117240311286015	0.0179231125878496	1	1	0.758049007530758	0.999999349769181	0.162610564133146
down	GJB3; GJB5; TRIP10; GJD3; KREMEN1; CCL19;	GO:0007154~cell communication	6	26	23.0769230769231	0.00122053479972151	0.0184856230347914	1	1	0.764054784625663	0.999999349769181	0.167714038245672
down	GSN; GSTP1; CD9; HES5; HDAC11; ZNF488;	GO:0014003~oligodendrocyte development	6	26	23.0769230769231	0.00122053479972151	0.0184856230347914	1	1	0.764054784625663	0.999999349769181	0.167714038245672
up	PSTPIP1; NRP2; PLXNC1; LPXN; ADA; CD4; FN1; ITGB3; ITGB2; GP1BA; THBS1; HCK; ITGAM; CCL4; CCL2; SELL; CD44; SELP; CD36; ENG; CD22; ITGAL; ITGAX; S1PR1; CD72; IL32; FPR2; L1CAM; CCR1; THBS2; GP5; CX3CR1; CXCR3; CCR3; BMX; CDH11; SIRPA; SRPX; SPOCK1; SLAMF1; LAMC2; SELPLG; ADGRE1; NEDD9; MYBPC3; COL19A1; THEMIS2; OLFM4; HAS1; CSF3R; FEZ1; OMD; EMILIN2; LY9; NTM; SIRPG; CD300A; ADGRE2; CLEC4A; LOXL2; NINJ2; SIGLEC5; SIGLEC12; ICAM2; SIGLEC14; FES; SIGLEC9; SIGLEC16; CD33; ICAM5; NINJ1; TGFBI;	GO:0007155~cell adhesion	72	454	15.8590308370044	0.00125222079215048	0.107119322111134	1	1	1	1	0.94854254906793
down	CHCHD10; KCNK6; KCNK1; KCNK7; KCNK5;	GO:0030322~stabilization of membrane potential	5	17	29.4117647058824	0.00126528517635216	0.0190454617929685	1	1	0.769779960189193	0.999999349769181	0.17279327299603
down	EGFR; C1QA; SMO; TREM2; BACE2;	GO:0048143~astrocyte activation	5	17	29.4117647058824	0.00126528517635216	0.0190454617929685	1	1	0.769779960189193	0.999999349769181	0.17279327299603
down	FZD7; EFNA1; ITGA8; EPHB3; RAC1; TEK; AKIP1; PARVA;	GO:0034446~substrate adhesion-dependent cell spreading	8	48	16.6666666666667	0.00128223540895567	0.0192413976092366	1	1	0.771905716191312	0.999999349769181	0.17457093485365
up	TLR4; HP; PPBP; IL10; GNLY; FPR2; CFP; SLC11A1; CAMP; IRF8; DEFB108B; CLEC4D; NLRP1; NLRC4; CLEC4E; TLR6; IGLC3; TRBC1; IGHG1; IGHV1-2; TRBC2; IGHV3-30; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV4-34; IGHV3-35; FCER1G; IGHV1-69-2; TRDC; IGHV3-43; IGKC; IGHM; MPO; IGHV3-11; IGHV4-59;	GO:0042742~defense response to bacterium	40	216	18.5185185185185	0.00133987524169621	0.109596922641729	1	1	1	1	0.970481723780268
down	CCL21; SOX18; HES1; IHH; HES5; CCL19; EPAS1;	GO:0048469~cell maturation	7	37	18.9189189189189	0.00134160636202929	0.020009568058071	1	1	0.779473296339018	0.999999349769181	0.181540295193441
up	TRAV19; PSMB11; PIK3CD; BTN3A1; GRAP2; CD4; TRBV12-3; TRAV8-4; TRAC; TRBC1; CD3D; TRBV7-9; TRAV29DV5; LCK; CD3E; PTPRC; CD3G; CD247; GATA3; PSMB9; PSMB10; WAS; ZAP70; ITK; PTPRJ; TRAT1; SKAP1; PSMA8; INPP5D; CARD11; THEMIS2; PRAM1; HHLA2; CTLA4;	GO:0050852~T cell receptor signaling pathway	34	174	19.5402298850575	0.00136473931625025	0.109596922641729	1	1	1	1	0.970481723780268
down	TP73; C1QA; HSPB1; SLC25A5; KRT18; ANXA2; KRT7; UNG; FDPS; PDGFRA; FBLN1; PSMB6; PSMB5; FCGR2B; APLNR; KDR; LTBR; IFI27; TSPAN7; TUFM; BCAP31; DYNLL1; C1QBP; TRIM28; KEAP1; RAET1L; RAET1G; NLRX1; ULBP2; TRIM6; TMEM134; KCTD5; NCKAP1;	GO:0016032~viral process	33	456	7.23684210526316	0.00142815415126851	0.0211073417160289	1	1	0.790456975228711	0.999999349769181	0.19150003811957
down	XYLB; COX6C; COX8A; FDXR; AVPR1A; PHKA1; GYS2; COX4I2;	GO:0006091~generation of precursor metabolites and energy	8	49	16.3265306122449	0.00144203632862439	0.021146201451694	1	1	0.792170505639035	0.999999349769181	0.191852599847205
down	YAP1; TJP1; AMOTL1; TEAD3; WWTR1; AMOTL2;	GO:0035329~hippo signaling	6	27	22.2222222222222	0.00144375128472318	0.021146201451694	1	1	0.792603963864869	0.999999349769181	0.191852599847205
down	RAMP2; ANXA1; HSPB1; MT1G; KDR; DLL4;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	6	27	22.2222222222222	0.00144375128472318	0.021146201451694	1	1	0.792603963864869	0.999999349769181	0.191852599847205
up	NCR3; SH2D1A; IL18RAP; CRTAM; CD160; LAG3; STAT5B; SLAMF6; IL21;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	9	21	42.8571428571429	0.00144999062036155	0.114114261822454	1	1	1	1	1
down	CA2; IGFBP2; SRD5A1; GSTM3; COMT; CCND1; CD24; TEK; CITED4;	GO:0043627~response to estrogen	9	62	14.5161290322581	0.00155517691392948	0.0223348063945387	1	1	0.806636068165477	0.999999349769181	0.202636425443348
down	CES2; GSTA1; AKR1C2; PTGR1; PTGR2;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	BMP2; BMP4; AVPR1A; HES1; HES5;	GO:0021537~telencephalon development	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	PLA2G2A; PLA2G4A; LPCAT4; PLA2G4F; PLA2G2F;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	TUBB4B; PRDX1; RAET1G; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	PDGFRA; FGFR2; FOXF1; IHH; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	CXCL10; S100A7; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	FGF1; FUT1; TJP1; SMAD1; JMJD8;	GO:1903672~positive regulation of sprouting angiogenesis	5	18	27.7777777777778	0.00156599317116246	0.0223348063945387	1	1	0.80805247631983	0.999999349769181	0.202636425443348
down	CPE; FOXF1; SFRP2; HEY2;	GO:0003214~cardiac left ventricle morphogenesis	4	10	40	0.00159164209862661	0.0225690236129895	1	1	0.81023058758126	0.999999349769181	0.204761401997243
down	SLC1A3; SLC1A1; CXADR; ABCG2;	GO:0070633~transepithelial transport	4	10	40	0.00159164209862661	0.0225690236129895	1	1	0.81023058758126	0.999999349769181	0.204761401997243
down	MYO1D; PPP1R26; ARFGEF3; DLG3; LMTK3; PKMYT1; SH2D4A; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	8	50	16	0.00161723253687152	0.0226690589409039	1	1	0.812179327999439	0.999999349769181	0.205668989952497
down	EPN2; ELF3; HES1; HES5; MESP1; TP63; DLL4; RFNG;	GO:0045747~positive regulation of Notch signaling pathway	8	50	16	0.00161723253687152	0.0226690589409039	1	1	0.812179327999439	0.999999349769181	0.205668989952497
down	GIPC1; PTN; ITPKA; CX3CL1; FGF14; PLK2; BAIAP2; LZTS1;	GO:0048167~regulation of synaptic plasticity	8	50	16	0.00161723253687152	0.0226690589409039	1	1	0.812179327999439	0.999999349769181	0.205668989952497
up	CCDC88B; LCK; CCL2; CCR2; FAM49B; SIRPG; SIRPA; SIRPB1;	GO:0050870~positive regulation of T cell activation	8	17	47.0588235294118	0.00167072415175351	0.126428837252886	1	1	1	1	1
down	SLC25A5; GJA1; SLC25A1; SLC25A43; SLC25A21; SLC25A23;	GO:0015867~ATP transport	6	28	21.4285714285714	0.00169674807019971	0.0235809419301618	1	1	0.81811561708843	0.999999349769181	0.213942207373849
down	GPX3; PRDX2; PRDX1; DUOX2; DUOX1; PRDX4;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00169674807019971	0.0235809419301618	1	1	0.81811561708843	0.999999349769181	0.213942207373849
down	RAB38; ATP6V1F; ATP6V1C2; ATP6V0A4; SLAMF8; ATP6V1D;	GO:0090383~phagosome acidification	6	28	21.4285714285714	0.00169674807019971	0.0235809419301618	1	1	0.81811561708843	0.999999349769181	0.213942207373849
down	APOE; GSTP1; BMP4; BMP7; HYAL2; CBLC; SPRY1;	GO:0043407~negative regulation of MAP kinase activity	7	39	17.9487179487179	0.00175319710543664	0.0235974192287989	1	1	0.82214670803869	0.999999349769181	0.214091700538813
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	GOT2; ALDH4A1; HOGA1;	GO:0019470~4-hydroxyproline catabolic process	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	LMNA; KIF2C; CAMSAP3;	GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	ERBB2; BMP4; IHH;	GO:0033088~negative regulation of immature T cell proliferation in thymus	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	PLD2; PLD1; TNFAIP8L3;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	AGR2; VAMP2; VAMP8;	GO:0070254~mucus secretion	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	TEK; HES1; ANGPT1;	GO:0072012~glomerulus vasculature development	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	CLDN5; CLDN12; ACTG1;	GO:0120192~tight junction assembly	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0017606414592215	0.0235974192287989	1	1	0.822444714308129	0.999999349769181	0.214091700538813
down	RARG; PTN; PTPRZ1; HES5; NKX6-2;	GO:0031641~regulation of myelination	5	19	26.3157894736842	0.00191605730640521	0.0253333847106332	1	1	0.831568870979859	0.999999349769181	0.22984155006596
down	PLA2G2A; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	5	19	26.3157894736842	0.00191605730640521	0.0253333847106332	1	1	0.831568870979859	0.999999349769181	0.22984155006596
down	RHOD; RAPGEF3; PDGFRA; ARHGDIA; PHPT1;	GO:2000249~regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.00191605730640521	0.0253333847106332	1	1	0.831568870979859	0.999999349769181	0.22984155006596
down	SPRY1; BMP7; ITGA8; IRX3; APH1A; SOX17;	GO:0001656~metanephros development	6	29	20.6896551724138	0.0019819999252263	0.0257881525508929	1	1	0.833578627058369	0.999999349769181	0.233967510592725
down	DVL1; PHGDH; HES5; ZNF358; INTU; GRHL2;	GO:0021915~neural tube development	6	29	20.6896551724138	0.0019819999252263	0.0257881525508929	1	1	0.833578627058369	0.999999349769181	0.233967510592725
down	IL33; SCGB1A1; C1QBP; GAS6; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	6	29	20.6896551724138	0.0019819999252263	0.0257881525508929	1	1	0.833578627058369	0.999999349769181	0.233967510592725
down	CXCL11; CXCL10; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.0019819999252263	0.0257881525508929	1	1	0.833578627058369	0.999999349769181	0.233967510592725
down	BMP2; BMP7; FGFR2; WNT4; FOXF2; TRIM28; FAM83D;	GO:0001837~epithelial to mesenchymal transition	7	40	17.5	0.00199262503357267	0.0257881525508929	1	1	0.833884025012948	0.999999349769181	0.233967510592725
down	PIGR; IGHA1; KRT1; HSPB1; ACTG1; PRDX1; ZG16B;	GO:0001895~retina homeostasis	7	40	17.5	0.00199262503357267	0.0257881525508929	1	1	0.833884025012948	0.999999349769181	0.233967510592725
down	SCGB1A1; PRLR; FBLN1; STC1; EMP2; DDR1; TRIM28;	GO:0007566~embryo implantation	7	40	17.5	0.00199262503357267	0.0257881525508929	1	1	0.833884025012948	0.999999349769181	0.233967510592725
down	CHP2; CDK1; CDH1; JUP; HYAL2; TRIM28; SMO;	GO:0042307~positive regulation of protein import into nucleus	7	40	17.5	0.00199262503357267	0.0257881525508929	1	1	0.833884025012948	0.999999349769181	0.233967510592725
down	ANXA4; SCGB1A1; ANXA3; NQO1; PLN; SERPINB3; UGT1A8; HSPBP1;	GO:0043086~negative regulation of catalytic activity	8	52	15.3846153846154	0.00201792412043977	0.0259686077887499	1	1	0.834661437774931	0.999999349769181	0.235604722203426
down	GABRQ; GABRD; HTR3A; GABRB2; HTR3B; CHRNB4; GABRE; GABRA4;	GO:0050877~nervous system process	8	52	15.3846153846154	0.00201792412043977	0.0259686077887499	1	1	0.834661437774931	0.999999349769181	0.235604722203426
down	ADGRL2; TSPAN12; EGFR; HRAS; CXCL10; ERBB2; INHA; CD59; EDN3; CXCR1; BDKRB2; ADGRF1; GPR157; ADGRG6; ADGRF5; ADGRF4; ADGRG7; ADGRL4; CBLC; ADGRG1; CTF1; ANXA1;	GO:0007166~cell surface receptor signaling pathway	22	268	8.2089552238806	0.00205266199444265	0.0262869698345902	1	1	0.835621480836553	0.999999349769181	0.2384931173758
down	TTC26; BMP4; FOXF1; HES1; IHH; NSDHL; HES5; TMEM17; SMO;	GO:0007224~smoothened signaling pathway	9	65	13.8461538461538	0.00208351664393647	0.0266059599491229	1	1	0.836612493029196	0.999999349769181	0.241387210810901
down	APOE; ACHE; KLK6; APH1A;	GO:0042982~amyloid precursor protein metabolic process	4	11	36.3636363636364	0.00210476420693184	0.0266059599491229	1	1	0.837291120943724	0.999999349769181	0.241387210810901
down	YES1; BDKRB2; CDH5; TEK;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.00210476420693184	0.0266059599491229	1	1	0.837291120943724	0.999999349769181	0.241387210810901
down	IRF6; KLK8; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00210476420693184	0.0266059599491229	1	1	0.837291120943724	0.999999349769181	0.241387210810901
down	ADCY6; EFNA5; GNAI1; ADCY2;	GO:1904322~cellular response to forskolin	4	11	36.3636363636364	0.00210476420693184	0.0266059599491229	1	1	0.837291120943724	0.999999349769181	0.241387210810901
up	TLR4; ITGB2; CD14; ITGAM; SCIMP; PIK3AP1; TNIP3; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	8	18	44.4444444444444	0.00221327360151802	0.159474097903855	1	1	1	1	1
up	PIK3CD; PECAM1; PRTN3; PIK3CG; JAML;	GO:0072672~neutrophil extravasation	5	6	83.3333333333333	0.00222898993258247	0.159474097903855	1	1	1	1	1
down	PSMD3; ARHGEF15; CAPN1; CALML3; GPSM2; RNF180; CALML6; CALML5;	GO:0050790~regulation of catalytic activity	8	53	15.0943396226415	0.00224555262836579	0.0280952518106533	1	1	0.841498614013792	0.999999349769181	0.254899070906369
down	RAMP3; AGR2; EGFR; RAB11A; PLS1; ARHGEF16; NKD2; TREM2;	GO:1903078~positive regulation of protein localization to plasma membrane	8	53	15.0943396226415	0.00224555262836579	0.0280952518106533	1	1	0.841498614013792	0.999999349769181	0.254899070906369
down	RAB11A; CHMP4C; MVB12A; VPS25; CHMP1A; CHMP3;	GO:0036258~multivesicular body assembly	6	30	20	0.00230204234656173	0.0287285488759693	1	1	0.84309671227186	0.999999349769181	0.26064476895687
down	PARVA; NCKAP1; RHOV; RHOJ; RAC1;	GO:0030031~cell projection assembly	5	20	25	0.00232003464061081	0.028806115385452	1	1	0.843715736110595	0.999999349769181	0.261348504639107
down	NTF4; HAP1; BCAR1; AKT1S1; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	5	20	25	0.00232003464061081	0.028806115385452	1	1	0.843715736110595	0.999999349769181	0.261348504639107
down	BMP2; BMP4; BMP7; SERPINB3; FOXC1; BAMBI; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	7	42	16.6666666666667	0.00254668041574568	0.0311459014845697	1	1	0.850577941164994	0.999999349769181	0.28257662200229
down	CA12; CA2; CA4; AQP1; CYB5R2; SLC26A9; SLC4A11;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.00254668041574568	0.0311459014845697	1	1	0.850577941164994	0.999999349769181	0.28257662200229
down	FOXP2; EFEMP1; FOXC1; SHROOM2; HES5; GRHL2; STRA6;	GO:0043010~camera-type eye development	7	42	16.6666666666667	0.00254668041574568	0.0311459014845697	1	1	0.850577941164994	0.999999349769181	0.28257662200229
up	HLA-G; HLA-F; ARRB2; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	6	10	60	0.00259290371673959	0.180216492721345	1	1	1	1	1
up	PIK3CD; F2; FGR; CSF3; CCL5; OSM; HGF; HCLS1; NCF1; SELP; EPOR; F2R; PTPN6; FLT3; PIK3CG; TGFB2; PRR5L; PIK3AP1; PIK3R5; HCST;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	20	87	22.9885057471264	0.0026105057395468	0.180216492721345	1	1	1	1	1
down	ZWINT; NEK2; KIFC1; CDCA8; TUBG1; KIF18B;	GO:0000070~mitotic sister chromatid segregation	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	MID1; HOXB1; SOSTDC1; GRHL3; FOXJ1; RFNG;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	EGFR; KDR; DDR1; YES1; PTK6; FRK;	GO:0038083~peptidyl-tyrosine autophosphorylation	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	EGFR; ERBB2; ERBB3; BTC; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	CCL21; PDGFRA; FGFR3; TEK; TNFAIP8L3; CCL19;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	CLDN5; PDGFRA; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	NEK2; RAB11A; CDC20; MISP; KIFC1; BIRC5;	GO:0090307~mitotic spindle assembly	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	PRMT5; CLDN1; EGFR; CCND1; IHH; HFE;	GO:0097421~liver regeneration	6	31	19.3548387096774	0.0026594635887669	0.0314265679220304	1	1	0.853717634984404	0.999999349769181	0.285123017194812
down	ADH1B; ADH1C; ADH7; ACSS2;	GO:0006069~ethanol oxidation	4	12	33.3333333333333	0.00272157814681373	0.0314265679220304	1	1	0.855671222249814	0.999999349769181	0.285123017194812
down	UQCRQ; SRD5A1; PTN; SMO;	GO:0021794~thalamus development	4	12	33.3333333333333	0.00272157814681373	0.0314265679220304	1	1	0.855671222249814	0.999999349769181	0.285123017194812
down	SCD; SLC25A1; HSD17B8; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	4	12	33.3333333333333	0.00272157814681373	0.0314265679220304	1	1	0.855671222249814	0.999999349769181	0.285123017194812
down	BCAR1; RAC1; MST1R; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	4	12	33.3333333333333	0.00272157814681373	0.0314265679220304	1	1	0.855671222249814	0.999999349769181	0.285123017194812
down	SPINK1; NTF3; CADM4; SFRP2;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	4	12	33.3333333333333	0.00272157814681373	0.0314265679220304	1	1	0.855671222249814	0.999999349769181	0.285123017194812
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	BMP4; IHH; FOXJ1;	GO:0033085~negative regulation of T cell differentiation in thymus	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	TOLLIP; PRDX2; PRDX1;	GO:0045321~leukocyte activation	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	KRT10; KRT2; TMEM79;	GO:0045684~positive regulation of epidermis development	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	LMNA; PTN; CTNNBIP1;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	AKR1B10; AKR1A1; RDH12;	GO:0110095~cellular detoxification of aldehyde	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	FUT1; CEACAM6; TSTA3;	GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin	3	5	60	0.00273665534235179	0.0314265679220304	1	1	0.856247140959052	0.999999349769181	0.285123017194812
down	RAPGEF3; SLC25A5; ADRA2A; SLC2A1; ADRA2C; HNF4A; ICA1; TFAP2B; KCNS3;	GO:0050796~regulation of insulin secretion	9	68	13.2352941176471	0.00274579322320123	0.0314576591285724	1	1	0.85653816371106	0.999999349769181	0.285405097587411
down	F12; PCSK6; PSEN2; APH1A; KLK13; CPZ; CPXM1; CPE;	GO:0016485~protein processing	8	55	14.5454545454545	0.00276092385201931	0.0315103683101216	1	1	0.856831257799382	0.999999349769181	0.2858833108277
down	BMP2; BMP4; SIK1; MESP1; CBY1;	GO:0055007~cardiac muscle cell differentiation	5	21	23.8095238095238	0.00278252807573309	0.0315826620568127	1	1	0.857423749074699	0.999999349769181	0.286539208450121
down	ANXA1; KDR; FGFBP1; RHOJ; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00278252807573309	0.0315826620568127	1	1	0.857423749074699	0.999999349769181	0.286539208450121
down	MYO1C; RHOD; GIPC1; SYNGR1; AP1S3; AP1M2; HAP1;	GO:0006605~protein targeting	7	43	16.2790697674419	0.00286459907325209	0.0322894439316803	1	1	0.859745891302036	0.999999349769181	0.292951610248523
up	S1PR1; IL10; CORO1A; GPR183; CXCR5; CNR2; CXCL5; PPBP; IL16;	GO:0030595~leukocyte chemotaxis	9	24	37.5	0.00300679809464388	0.193963122990552	1	1	1	1	1
down	E2F8; RAMP2; TEK; ANGPT1; PARVA; KDR;	GO:0002040~sprouting angiogenesis	6	32	18.75	0.00305689650824403	0.0342989397209399	1	1	0.864510065099064	0.999999349769181	0.311183111184148
down	KCNK5; SCNN1B; SCNN1G; AMN; ATP6V0A4; CLDN16;	GO:0007588~excretion	6	32	18.75	0.00305689650824403	0.0342989397209399	1	1	0.864510065099064	0.999999349769181	0.311183111184148
down	CLEC3B; BMP2; PTN; FGFR2; FGFR3; GPNMB; LGR4;	GO:0030282~bone mineralization	7	44	15.9090909090909	0.00321203015871396	0.0359570973373655	1	1	0.868071944024237	0.999999349769181	0.326227035285334
down	BMP7; FGFR2; IHH; SMAD1; RIPPLY3;	GO:0009880~embryonic pattern specification	5	22	22.7272727272727	0.00330816252987487	0.0369487011327577	1	1	0.870314196278174	0.999999349769181	0.335223533620931
down	IGHA1; CD34; MYO1E; ADGRF5;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	XDH; NT5C; NUDT15; GDA;	GO:0006195~purine nucleotide catabolic process	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	NQO1; PRDX2; SOD3; PRDX1;	GO:0019430~removal of superoxide radicals	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	CCL21; CDC42EP1; CDC42EP5; CDC42EP4;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	ELOVL1; ELOVL4; TECR; ELOVL6;	GO:0042761~very long-chain fatty acid biosynthetic process	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	ID4; HES1; HES5; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	EGFR; TFAP2A; GRHL3; STRA6;	GO:0061029~eyelid development in camera-type eye	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	GRHL3; SFRP2; FZD1; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	4	13	30.7692307692308	0.00345163045074925	0.0377748907495869	1	1	0.873754173338562	0.999999349769181	0.34271928297892
down	SAA1; CX3CL1; CCL21; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	6	33	18.1818181818182	0.00349701027143123	0.038101056231273	1	1	0.874845267384148	0.999999349769181	0.34567847618366
down	SPINT2; BMP2; BMP4; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	6	33	18.1818181818182	0.00349701027143123	0.038101056231273	1	1	0.874845267384148	0.999999349769181	0.34567847618366
up	LPXN; CD22; FCRL3; CD300A; PLCL2;	GO:0050859~negative regulation of B cell receptor signaling pathway	5	7	71.4285714285714	0.00352212777823691	0.220907692542002	1	1	1	1	1
down	MUC21; CLDN7; ERBB3; FBLN1; ARHGDIA; JAM2; ANGPT1;	GO:0007162~negative regulation of cell adhesion	7	45	15.5555555555556	0.00359070058642796	0.0389483531459104	1	1	0.877116322863647	0.999999349769181	0.353365725181407
down	PAK4; BMP2; CCNB1; FOXF1; KLF5; SMAD1; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	7	45	15.5555555555556	0.00359070058642796	0.0389483531459104	1	1	0.877116322863647	0.999999349769181	0.353365725181407
up	PIK3CD; CCL3; GPR183; PIK3CG; CXCR3; CCL26;	GO:0010818~T cell chemotaxis	6	11	54.5454545454545	0.00368620364861516	0.220907692542002	1	1	1	1	1
up	CD3D; PTPRC; ZAP70; DOCK2; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	6	11	54.5454545454545	0.00368620364861516	0.220907692542002	1	1	1	1	1
up	CD3E; PTPRC; CCR7; ZAP70; DOCK2; AIRE;	GO:0045060~negative thymic T cell selection	6	11	54.5454545454545	0.00368620364861516	0.220907692542002	1	1	1	1	1
up	CYBB; CYBA; NCF1; NCF2; PREX1; NCF1B; NCF1C; NCF4;	GO:0006801~superoxide metabolic process	8	20	40	0.00370518620273752	0.220907692542002	1	1	1	1	1
up	CFD; SERPINA1; TIMP1; FN1; PPBP; ITGB3; SERPINE1; THBS1; ITGA2B; PLEK; ANXA5; SRGN; F5; HGF; SELP; PECAM1; CD36; ORM2; CTSW; TGFB2; ITIH3; LHFPL2; FERMT3; SCG3; FAM49B;	GO:0002576~platelet degranulation	25	124	20.1612903225806	0.00385980705547562	0.226691653183531	1	1	1	1	1
down	TLCD2; SLC9A3R1; TLCD1; BAIAP2; FER1L6;	GO:0007009~plasma membrane organization	5	23	21.7391304347826	0.00390156187530766	0.0409869816329893	1	1	0.884734986812116	0.999999349769181	0.371861537597746
down	EGFR; CEACAM1; PTPN13; PIP4K2C; CRNN;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	5	23	21.7391304347826	0.00390156187530766	0.0409869816329893	1	1	0.884734986812116	0.999999349769181	0.371861537597746
down	CYP11A1; FDXR; EBPL; CYP39A1; CYP26B1;	GO:0016125~sterol metabolic process	5	23	21.7391304347826	0.00390156187530766	0.0409869816329893	1	1	0.884734986812116	0.999999349769181	0.371861537597746
down	TUBA1B; TUBA1C; TUBG1; TUBB4B; TUBB6; TUBB2A;	GO:0007017~microtubule-based process	6	34	17.6470588235294	0.00398250198475603	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	VSNL1; RAC1; TRPM4; BAD; PHPT1; SYBU;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	6	34	17.6470588235294	0.00398250198475603	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	FOXP2; BMP4; FGFR2; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00398250198475603	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	MPST; TST; TXN2;	GO:0000098~sulfur amino acid catabolic process	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	ANXA2; EMP2; S100A10;	GO:0001765~membrane raft assembly	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	BMP4; HEY2; FZD1;	GO:0003150~muscular septum morphogenesis	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	PRDX2; RAC1; NOXA1;	GO:0010310~regulation of hydrogen peroxide metabolic process	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	F12; CLEC3B; ENO1;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	BGN; EGFLAM; NDNF;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	WRNIP1; CDT1; WDR18;	GO:0030174~regulation of DNA-dependent DNA replication initiation	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	ALOX12; ALOX15B; ALOX12B;	GO:0034440~lipid oxidation	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	PLTP; CPTP; GLTP;	GO:0046836~glycolipid transport	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	FGFR2; FLG2; KLK14;	GO:0048730~epidermis morphogenesis	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	NMU; TFF2; PTGER3;	GO:0060455~negative regulation of gastric acid secretion	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	EGFR; ERBB2; LGMN;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	CDH5; ACTG1; TJP1;	GO:1902396~protein localization to bicellular tight junction	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00398810369119029	0.0409869816329893	1	1	0.886615193102023	0.999999349769181	0.371861537597746
down	PLS3; GJA1; SRD5A1; FGFR2; BGN; STC1; SMAD1;	GO:0060348~bone development	7	46	15.2173913043478	0.00400236344168881	0.041047299699668	1	1	0.887097114663704	0.999999349769181	0.372408783775104
down	SULT2B1; LRP5; APOE; CYP11A1; CYP2C9; FDXR; VLDLR; EBP; NSDHL;	GO:0008203~cholesterol metabolic process	9	73	12.3287671232877	0.00420851449250603	0.0429476311803392	1	1	0.891756666046441	0.999999349769181	0.389649872486526
up	TLR2; CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	4	4	100	0.00423008410932635	0.234441985495763	1	1	1	1	1
up	TLR2; CD14; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	4	4	100	0.00423008410932635	0.234441985495763	1	1	1	1	1
up	TLR2; CD14; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	4	4	100	0.00423008410932635	0.234441985495763	1	1	1	1	1
down	GRHL3; DLG3; TP63; INTU;	GO:0001736~establishment of planar polarity	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	APOE; FABP1; SLC27A4; SLC27A6;	GO:0015909~long-chain fatty acid transport	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	GSTP1; CX3CL1; FFAR4; TREM2;	GO:0032691~negative regulation of interleukin-1 beta production	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	PRDX2; MAP3K6; PRDX1; PRDX4;	GO:0033554~cellular response to stress	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	GHR; FOXA1; WNT4; KLK6;	GO:0042445~hormone metabolic process	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	GSTP1; SERPINB3; SFRP2; MAPK8IP1;	GO:0043508~negative regulation of JUN kinase activity	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	ADRA2A; PLN; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	E2F8; SOX15; GJB5; MDFI;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	MEIS2; ANXA3; SOX2; LUM;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00430413705535271	0.0430589743860643	1	1	0.893746790478681	0.999999349769181	0.390660053134926
down	LRP5; TFF1; GJA1; BMP7; GNAI1; TEK; ANXA1;	GO:0043434~response to peptide hormone	7	47	14.8936170212766	0.00444879429230671	0.0441150108287099	1	1	0.896897820829728	0.999999349769181	0.400241127897587
down	TGFA; FGF1; PTN; FGFR2; BTC; MACC1; GKN1;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.00444879429230671	0.0441150108287099	1	1	0.896897820829728	0.999999349769181	0.400241127897587
down	CIDEA; NR1D1; ID1; ACOT11; PGAM5; LGR4; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	7	47	14.8936170212766	0.00444879429230671	0.0441150108287099	1	1	0.896897820829728	0.999999349769181	0.400241127897587
down	NKX2-8; NUPR1; BMP4; PTN; CDKN2B; SOX2; MARVELD3; SFRP2;	GO:0050680~negative regulation of epithelial cell proliferation	8	60	13.3333333333333	0.00445478645735542	0.0441150108287099	1	1	0.896897820829728	0.999999349769181	0.400241127897587
down	SPRY1; EGFR; TGFA; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	6	35	17.1428571428571	0.00451608829121863	0.044541741775487	1	1	0.89855344694638	0.999999349769181	0.404112718819553
down	GABRD; GABRB2; GRIK4; FGF14; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	6	35	17.1428571428571	0.00451608829121863	0.044541741775487	1	1	0.89855344694638	0.999999349769181	0.404112718819553
down	RAMP2; RAMP3; RYR1; PLN; GJA4; CACNB3; BSPRY; TRPV4; PSEN2;	GO:0006816~calcium ion transport	9	74	12.1621621621622	0.00456290382668534	0.0446867250668606	1	1	0.899117864940693	0.999999349769181	0.405428105010683
down	DVL1; IL33; KEAP1; NKD2; PLK2; HSPBP1; RNF180; TRIB3; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	9	74	12.1621621621622	0.00456290382668534	0.0446867250668606	1	1	0.899117864940693	0.999999349769181	0.405428105010683
down	EFNA1; FOXA1; VASN; SFRP2; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.00456732676480587	0.0446867250668606	1	1	0.899688733426369	0.999999349769181	0.405428105010683
down	DVL1; HOXA1; MYO3A; GRHL3; FRZB;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00456732676480587	0.0446867250668606	1	1	0.899688733426369	0.999999349769181	0.405428105010683
up	SASH3; CD3E; RARA; TNFSF4; GATA3; CD40LG; FCER1G; NLRP3;	GO:0032753~positive regulation of interleukin-4 production	8	21	38.0952380952381	0.00469459044168863	0.253057717644449	1	1	1	1	1
up	TLR4; TYROBP; IFNG; CYBB; THBS1; TNFRSF8; CCR2; TLR1;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	8	21	38.0952380952381	0.00469459044168863	0.253057717644449	1	1	1	1	1
down	ATP6V1F; HFE; STEAP3; ATP6V1C2; ATP6V0A4; ATP6V1D;	GO:0033572~transferrin transport	6	36	16.6666666666667	0.00510049697969261	0.049595620402962	1	1	0.911049582051741	0.999999349769181	0.449964913891477
up	MYO1G; S1PR1; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	5	8	62.5	0.00527683863254746	0.276858133587657	1	1	1	1	1
down	SCD; ELOVL1; ELOVL4; ELOVL6;	GO:0006636~unsaturated fatty acid biosynthetic process	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	ICA1; SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	CTSV; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	ENTPD3; ENTPD8; NUDT15; ENTPD2;	GO:0034656~nucleobase-containing small molecule catabolic process	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	KRT14; KRT16; MPZL3; PPP1R13L;	GO:0042633~hair cycle	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	TACSTD2; SERPINB5; HES1; HES5;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	CIDEA; FCGR2B; FFAR4; LGR4;	GO:0050710~negative regulation of cytokine secretion	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	APOE; ADRA2A; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	KRT1; KRT10; HSD17B8; FARSB;	GO:0051290~protein heterotetramerization	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	MEIS1; TP73; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	BMP4; FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	PRDX1; UACA; TRIM6; AKIP1;	GO:1901222~regulation of NIK/NF-kappaB signaling	4	15	26.6666666666667	0.00528792526700195	0.049595620402962	1	1	0.914811071191337	0.999999349769181	0.449964913891477
down	CYP2E1; CYP2C9; CBR1; CYP2C19; CYP4F12;	GO:0017144~drug metabolic process	5	25	20	0.0053100134500017	0.049595620402962	1	1	0.914817254269469	0.999999349769181	0.449964913891477
down	CTSV; GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.0053100134500017	0.049595620402962	1	1	0.914817254269469	0.999999349769181	0.449964913891477
down	KDR; WNT4; S100A10; RAC1; TEK;	GO:0051894~positive regulation of focal adhesion assembly	5	25	20	0.0053100134500017	0.049595620402962	1	1	0.914817254269469	0.999999349769181	0.449964913891477
down	CDK1; CCNB1; FGFR2; YAP1; HEY2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	5	25	20	0.0053100134500017	0.049595620402962	1	1	0.914817254269469	0.999999349769181	0.449964913891477
down	CCNB2; IGFBP2; GAS6; IHH; IGSF11; KCTD11; NDN; RUVBL2;	GO:0040008~regulation of growth	8	62	12.9032258064516	0.00532028252125638	0.049595620402962	1	1	0.915088593656098	0.999999349769181	0.449964913891477
down	NDUFS4; NDUFB3; COQ9; NDUFS7; MT-ND3; NDUFB7; NDUFA5;	GO:0006120~mitochondrial electron transport, NADH to ubiquinone	7	49	14.2857142857143	0.0054531519938158	0.049595620402962	1	1	0.91749648784652	0.999999349769181	0.449964913891477
down	CIDEA; GSTP1; CD34; CX3CL1; GAS6; GPNMB; TREM2;	GO:0032720~negative regulation of tumor necrosis factor production	7	49	14.2857142857143	0.0054531519938158	0.049595620402962	1	1	0.91749648784652	0.999999349769181	0.449964913891477
down	S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	PHGDH; PSPH; PSAT1;	GO:0006564~L-serine biosynthetic process	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	ERBB3; GPC1; ADGRG6;	GO:0014037~Schwann cell differentiation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	HYAL2; GAS6; NECTIN2;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	ELOVL1; ELOVL4; ELOVL6;	GO:0019367~fatty acid elongation, saturated fatty acid	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	E2F8; CHMP4C; AURKB;	GO:0032466~negative regulation of cytokinesis	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	IGSF3; FGFR2; FOXC1;	GO:0032808~lacrimal gland development	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	GSTP1; FOXM1; PBK;	GO:0032873~negative regulation of stress-activated MAPK cascade	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	ELOVL1; ELOVL6; ELOVL4;	GO:0034625~fatty acid elongation, monounsaturated fatty acid	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	ELOVL4; ELOVL6; ELOVL1;	GO:0034626~fatty acid elongation, polyunsaturated fatty acid	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	AK4; AK3; AMPD1;	GO:0046033~AMP metabolic process	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	FGFR2; FOXF1; GRHL2;	GO:0060463~lung lobe morphogenesis	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	YAP1; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	RARG; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	IL33; CX3CL1; TREM2;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	SOX18; YAP1; SOX17;	GO:0072091~regulation of stem cell proliferation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	PROM1; CD24; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	RAMP2; HES1; HEY2;	GO:0097084~vascular smooth muscle cell development	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	SPINK1; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	CCL21; GAS6; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.00553540652903051	0.049595620402962	1	1	0.91889041342377	0.999999349769181	0.449964913891477
down	BIRC5; KALRN; RPS6KA4; CCNB2; MAP3K6; ERBB2; CDK1; BMP2; CCNO; ITPKA; CCND1; CCNF; FRK; CCL11; NEK2; SIK1; RIPK4; PTK6; FASTK; GAS6; ERN2; ADM2; PPP4R1; AURKB; ALPK3; LMTK3; TRIB3; PKMYT1; PLK2; MARK1; HSPB8; PHKA1;	GO:0006468~protein phosphorylation	32	482	6.63900414937759	0.00559528930236164	0.0500405032306273	1	1	0.920322528742862	0.999999349769181	0.454001190917871
down	E2F8; DLX3; GJB3; CCNF; ETNK2; PHLDA2;	GO:0001890~placenta development	6	37	16.2162162162162	0.00573845865203448	0.0510409813195504	1	1	0.923307783210829	0.999999349769181	0.4630782028289
down	NFIB; BMP2; BMP4; FGFR3; HES5; CYTL1;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00573845865203448	0.0510409813195504	1	1	0.923307783210829	0.999999349769181	0.4630782028289
down	RAMP3; EGFR; SRD5A1; BCL2L2; RUVBL2; SSTR1;	GO:0071392~cellular response to estradiol stimulus	6	37	16.2162162162162	0.00573845865203448	0.0510409813195504	1	1	0.923307783210829	0.999999349769181	0.4630782028289
down	SCNN1B; SCNN1G; FXYD3; SLC10A6; SLC5A8; SLC4A11; SLC5A5; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	9	77	11.6883116883117	0.00576659260136303	0.0511053822570071	1	1	0.923307783210829	0.999999349769181	0.463662491563305
down	P4HB; TXN; NQO1; NXN; TXN2; PTGES2; PRDX4; PRDX2; PRDX1;	GO:0045454~cell redox homeostasis	9	77	11.6883116883117	0.00576659260136303	0.0511053822570071	1	1	0.923307783210829	0.999999349769181	0.463662491563305
down	FOLR1; SOX18; IHH; SMO; MESP1; OVOL2; SOX17; TBX6;	GO:0001947~heart looping	8	63	12.6984126984127	0.00579839116985159	0.0511094227079531	1	1	0.924080561849699	0.999999349769181	0.46369914925903
down	GGT5; MSMO1; AACS; ACOT11; UGT1A8; CPT1C; ACOT7; FA2H;	GO:0006631~fatty acid metabolic process	8	63	12.6984126984127	0.00579839116985159	0.0511094227079531	1	1	0.924080561849699	0.999999349769181	0.46369914925903
down	NQO1; POR; IGFBP2; ALDH3A1; DAD1; AACS; SFRP2; SLC27A4;	GO:0007584~response to nutrient	8	63	12.6984126984127	0.00579839116985159	0.0511094227079531	1	1	0.924080561849699	0.999999349769181	0.46369914925903
down	MT1X; MT1A; MT1M; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	CSTA; CSTB; SERPINB3; SERPINB4;	GO:0010466~negative regulation of peptidase activity	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	ADRA2A; EDN3; BDKRB2; ACE2;	GO:0019229~regulation of vasoconstriction	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	ALOX15B; ALOX12B; ALOX12; ALOXE3;	GO:0019372~lipoxygenase pathway	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	CXCL10; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	EDN3; KEL; BDKRB2; TRPM4;	GO:0042310~vasoconstriction	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	ALOX12; DUOX2; DUOX1; NOXA1;	GO:0042554~superoxide anion generation	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	ROBO4; VSTM2L; PALLD; IGSF9;	GO:0070593~dendrite self-avoidance	4	16	25	0.00641138516220541	0.0557095847486836	1	1	0.933444307695638	0.999999349769181	0.505434921485008
down	CACNA1G; JUP; DSP; DSC2; DSG2; TRPM4;	GO:0086091~regulation of heart rate by cardiac conduction	6	38	15.7894736842105	0.00643269848731032	0.0557956755317767	1	1	0.933444307695638	0.999999349769181	0.506215995125919
down	PTN; PTPA; PPP1R26; PPP1R14C; PPP1R14B; PPME1; STYXL1;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	7	51	13.7254901960784	0.00661828327623826	0.0573037907740842	1	1	0.93538171804785	0.999999349769181	0.519898633625643
up	TYROBP; ITGB3; ITGB2; ITGA2B; PLEK; HCK; FGR; ITGAM; ITGAL; ITGAX; CD40LG; FCER1G; DAB2; NEDD9; FERMT3; TSPAN32; CCM2; ADAMTS1; LAMA3; PRAM1;	GO:0007229~integrin-mediated signaling pathway	20	96	20.8333333333333	0.00670821707274483	0.336832511432907	1	1	1	1	1
up	VNN1; APOA2; TNFSF4; TREM1; HP; HPR;	GO:0002526~acute inflammatory response	6	13	46.1538461538462	0.00684235885535678	0.336832511432907	1	1	1	1	1
up	TLR4; IL4; IL13; SLC11A1; TLR1; TMEM106A;	GO:0042116~macrophage activation	6	13	46.1538461538462	0.00684235885535678	0.336832511432907	1	1	1	1	1
up	ITGB2; PTPRC; CCL5; SELP; PECAM1; ITGAL; NT5E; CD40LG; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	9	28	32.1428571428571	0.00684792907614551	0.336832511432907	1	1	1	1	1
up	CNR2; MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	4	5	80	0.00704135908859194	0.337899366019625	1	1	1	1	1
up	PECAM1; CCR2; SIRPA; JAML;	GO:0035696~monocyte extravasation	4	5	80	0.00704135908859194	0.337899366019625	1	1	1	1	1
down	CCL21; JUP; FUT1; EMP2; CX3CL1;	GO:0001954~positive regulation of cell-matrix adhesion	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	ERBB2; ERBB3; UGT8; NTF3; NTF4;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	CDK1; CCNB1; CCND1; HSPA2; RAB11A;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	NDUFS4; RAPGEF3; DEFB1; ADCY2; ADGRG6;	GO:0019933~cAMP-mediated signaling	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	BMP4; CDH1; SRD5A1; SOX2; PITX1;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	CD34; RAC1; CTTN; PLD1; PLD2;	GO:0048870~cell motility	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	AP2S1; AP1S1; RAC1; AP1S3; AP1M2;	GO:0050690~regulation of defense response to virus by virus	5	27	18.5185185185185	0.00704403568474954	0.0599294305561648	1	1	0.939631521401089	0.999999349769181	0.543720208370646
down	TFAP2A; BMP2; BMP4; BMP7; PTN; WNT4;	GO:0030501~positive regulation of bone mineralization	6	39	15.3846153846154	0.00718592813765295	0.0605998660735567	1	1	0.941356586032537	0.999999349769181	0.549802851503285
down	EGFR; MT1A; GSN; MT1G; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	6	39	15.3846153846154	0.00718592813765295	0.0605998660735567	1	1	0.941356586032537	0.999999349769181	0.549802851503285
down	NR2F6; BMP4; RARG; BMP7; NR1D1; HNF4A; ESRRG;	GO:0043401~steroid hormone mediated signaling pathway	7	52	13.4615384615385	0.00726570771492341	0.0605998660735567	1	1	0.94196891324537	0.999999349769181	0.549802851503285
up	DNTT; SELL; SLC8A1; P2RX1; TRPC3; P2RX5; P2RX4;	GO:0033198~response to ATP	7	18	38.8888888888889	0.00736010423828048	0.342376041596599	1	1	1	1	1
up	SERPINE1; CCL5; FPR2; CCR1; CCR2; AIF1; PLA2G7;	GO:0090026~positive regulation of monocyte chemotaxis	7	18	38.8888888888889	0.00736010423828048	0.342376041596599	1	1	1	1	1
down	CCL21; CCL19; CYP26B1;	GO:0001768~establishment of T cell polarity	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	FUT1; FUT2; ANGPT1;	GO:0001936~regulation of endothelial cell proliferation	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	PLPP3; PLPP2; SGPP2;	GO:0006670~sphingosine metabolic process	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	YAP1; OVOL2; EPB41L4B;	GO:0010837~regulation of keratinocyte proliferation	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	TOM1L1; BMP4; BMP7;	GO:0045839~negative regulation of mitotic nuclear division	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	RAB5B; RAB11A; USP6NL;	GO:0048227~plasma membrane to endosome transport	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	CRABP2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	EXOC3L4; EXOC3L2; STXBP6;	GO:0051601~exocyst localization	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	PTN; IDH2; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	CD34; KDR; NDNF;	GO:0061042~vascular wound healing	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	ATP2C2; WNT4; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	GLTP; GLTPD2; CPTP;	GO:0120009~intermembrane lipid transfer	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	BMP2; DLX5; SMAD1;	GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	GLTPD2; CPTP; GLTP;	GO:1902389~ceramide 1-phosphate transport	3	8	37.5	0.00739536386874762	0.0605998660735567	1	1	0.943197034383891	0.999999349769181	0.549802851503285
down	CLDN5; IRF6; TFAP2A; PDGFRA; EPHB3; DLX5; FOXF2; INTU;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.00742982669983849	0.06078045521005	1	1	0.943587990879489	0.999999349769181	0.55144127793271
up	CD3E; PTPRC; TNFSF4; CCR2; ZAP70;	GO:0046641~positive regulation of alpha-beta T cell proliferation	5	9	55.5555555555556	0.00756968630721833	0.342376041596599	1	1	1	1	1
up	TLR4; CD36; TMEM106A; NLRC4; TLR6;	GO:0050702~interleukin-1 beta secretion	5	9	55.5555555555556	0.00756968630721833	0.342376041596599	1	1	1	1	1
down	CCL21; CXCR1; TRPM4; CCL19;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	UQCRH; COX7A2; UQCRC1; CHCHD10;	GO:0006119~oxidative phosphorylation	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	GCAT; GGT5; PHGDH; HGD;	GO:0006520~cellular amino acid metabolic process	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	DIO2; SLC5A5; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	CTSV; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	CCL21; CCL19; RARRES2; TREM2;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	KIF20A; CHMP4C; CHMP1A; CHMP3;	GO:0061952~midbody abscission	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	ZBTB7B; BMP7; FFAR4; SOX13;	GO:0090336~positive regulation of brown fat cell differentiation	4	17	23.5294117647059	0.00768242954166176	0.0617916514548383	1	1	0.94578255257025	0.999999349769181	0.560615532181708
down	NUPR1; FGFR4; PSEN2; MMP15; DAD1; NOXA1; APH1A; WRNIP1; MGST2;	GO:0043085~positive regulation of catalytic activity	9	81	11.1111111111111	0.00773572656912402	0.0618352522486188	1	1	0.946457532981733	0.999999349769181	0.561011107985774
down	BMP2; BMP4; TIMP2; ADRA2C; FOXA1; IRX3; DUOXA1; VWC2; SH3GL3;	GO:0045666~positive regulation of neuron differentiation	9	81	11.1111111111111	0.00773572656912402	0.0618352522486188	1	1	0.946457532981733	0.999999349769181	0.561011107985774
down	GJA1; GJB2; CX3CL1; EIF4EBP1; NDNF; BCL2L2; TREM2;	GO:0002931~response to ischemia	7	53	13.2075471698113	0.00795881120859987	0.0629785914912919	1	1	0.94855610844289	0.999999349769181	0.571384252624316
down	CCL21; YES1; CD24; EFNB2; RAC1; EFNB3; CCL19;	GO:0031295~T cell costimulation	7	53	13.2075471698113	0.00795881120859987	0.0629785914912919	1	1	0.94855610844289	0.999999349769181	0.571384252624316
down	FA2H; MCAT; FADS6; HSD17B8; MGLL; ELOVL4;	GO:0006633~fatty acid biosynthetic process	6	40	15	0.00800083779243577	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	ESYT3; B3GALNT1; GM2A; UGT8; CPTP; GLTP;	GO:0006687~glycosphingolipid metabolic process	6	40	15	0.00800083779243577	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	CTSV; GJA1; HNF4A; GYS2; VAMP2; GJD3; BAD; TXN2;	GO:0009749~response to glucose	8	67	11.9402985074627	0.00804373744305642	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	ZBTB7B; GOT2; SLC2A1; PLN; EIF6; GGH; TRPV4; KLF15;	GO:0032868~response to insulin	8	67	11.9402985074627	0.00804373744305642	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	MAPK13; CDK1; FABP1; NQO1; AQP1; LCN2; MAP1LC3A; ANXA1;	GO:0070301~cellular response to hydrogen peroxide	8	67	11.9402985074627	0.00804373744305642	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	BMP4; ELN; EFNA1; DLL4; HEY2;	GO:0003180~aortic valve morphogenesis	5	28	17.8571428571429	0.00804408647047206	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	LRP5; TGFA; EDN3; BTC; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	5	28	17.8571428571429	0.00804408647047206	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
down	CCNB1; FGFR2; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.00804408647047206	0.0629785914912919	1	1	0.949281304244452	0.999999349769181	0.571384252624316
up	VIL1; HCLS1; WAS; AIF1; CORO7; LMOD2; CATIP; PREX1; MSRB1;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.00822794747900668	0.36378621718979	1	1	1	1	1
up	ITGB3; ITGB2; CD2; PTPRC; CD1D; ITGAX; SIRPA; LILRB2; CD200R1;	GO:0034113~heterotypic cell-cell adhesion	9	29	31.0344827586207	0.00822794747900668	0.36378621718979	1	1	1	1	1
down	TGM5; ICMT; YES1; CPE; TGM1; MMP15; UBE2M; TGM3; RABGGTA;	GO:0006464~cellular protein modification process	9	82	10.9756097560976	0.0082996639361449	0.0629785914912919	1	1	0.95232021998433	0.999999349769181	0.571384252624316
down	KCNK1; KCNK5; AQP1; FXYD3; KCNS3; KCNG1; KCNK6; KCNK7;	GO:0006813~potassium ion transport	8	68	11.7647058823529	0.00869490569239362	0.0651385584183608	1	1	0.956439626163298	0.999999349769181	0.590980929194752
up	F2; SERPINE1; THBS1; CD36; TBXA2R; F2R;	GO:0030194~positive regulation of blood coagulation	6	14	42.8571428571429	0.00899702185717799	0.389047044043905	1	1	1	1	1
down	C1QA; TFF1; CCND1; HFE;	GO:0010039~response to iron ion	4	18	22.2222222222222	0.00910846162282364	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	CTSV; CRYAB; HYAL2; TP63;	GO:0010259~multicellular organism aging	4	18	22.2222222222222	0.00910846162282364	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	F12; CTSE; IHH; KLK6;	GO:0016540~protein autoprocessing	4	18	22.2222222222222	0.00910846162282364	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	PDLIM1; ELN; ITGB5; FHDC1;	GO:0043149~stress fiber assembly	4	18	22.2222222222222	0.00910846162282364	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	RAPGEF3; SOX18; MARVELD2; ROBO4;	GO:0061028~establishment of endothelial barrier	4	18	22.2222222222222	0.00910846162282364	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	KDR; IHH; SFRP2; DLL4; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	BMP4; FGFR3; DLX5; TEK; FOXC1;	GO:0001958~endochondral ossification	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	GIPC1; GOT1; CDKN2B; ITGA8; NPNT;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	TP73; NUPR1; TP63; PHLDA3; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	EGFR; HRAS; CDK1; RAC1; CDT1;	GO:0045740~positive regulation of DNA replication	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	HFE; STEAP3; EPAS1; STEAP1; HEPH;	GO:0055072~iron ion homeostasis	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	EGFR; ERBB2; ERBB3; BTC; CADM4;	GO:2000145~regulation of cell motility	5	29	17.2413793103448	0.00913845516014788	0.0671251090742394	1	1	0.96008370003855	0.999999349769181	0.609004256406929
down	PAK4; CEACAM1; IGFBP4; BCAR1; DDR1; LTBP4; ATAD3A; PAK5;	GO:0001558~regulation of cell growth	8	69	11.5942028985507	0.00938465786272358	0.0681286827908535	1	1	0.963005439843902	0.999999349769181	0.618109353939957
down	BHLHE40; FZD6; NUPR1; TBX6; ID1; KEAP1; GAS6; CTNNBIP1;	GO:0043433~negative regulation of DNA-binding transcription factor activity	8	69	11.5942028985507	0.00938465786272358	0.0681286827908535	1	1	0.963005439843902	0.999999349769181	0.618109353939957
down	BMP2; FGFR2; HEY2; WNT7B; SOX13; WNT4; SOX2;	GO:0045165~cell fate commitment	7	55	12.7272727272727	0.0094893469942896	0.0681286827908535	1	1	0.964021697167503	0.999999349769181	0.618109353939957
down	RARG; IHH; GRHL2; PPP1R13L; SMO; WWTR1; SLITRK6; ETNK2; UNC79;	GO:0035264~multicellular organism growth	9	84	10.7142857142857	0.00952056989770178	0.0681286827908535	1	1	0.964021697167503	0.999999349769181	0.618109353939957
down	BMP4; ERBB3; FOXF1;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	GRHL2; DLL4; HEY2;	GO:0003208~cardiac ventricle morphogenesis	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	IDO1; TDO2; AADAT;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	PLA2G4A; CYP2J2; CYP4F22;	GO:0006690~icosanoid metabolic process	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	MATN2; CD9; NDN;	GO:0008347~glial cell migration	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	CCND1; YAP1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	KLK8; JAM2; TMEM98;	GO:0031642~negative regulation of myelination	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	ABCA12; ADGRF5; EPAS1;	GO:0043129~surfactant homeostasis	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	AKR1B10; AKR1A1; AKR1C2;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	AKR1B10; AKR1A1; AKR1C2;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	HMGCS2; BDH1; AACS;	GO:0046951~ketone body biosynthetic process	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	RARG; ALDH1A3; EFEMP1;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	FZD7; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	RAB25; RAB11A; VAMP2;	GO:0060627~regulation of vesicle-mediated transport	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	GSN; EFS; BCAR1;	GO:0090527~actin filament reorganization	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	SLC25A5; BOK; TMEM14A;	GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	GPR37; TXN; PYCR1;	GO:1903206~negative regulation of hydrogen peroxide-induced cell death	3	9	33.3333333333333	0.00958146642684121	0.0681286827908535	1	1	0.965060289816897	0.999999349769181	0.618109353939957
down	CLDN1; CLEC3B; YES1; FGFR2; WNT4; HYAL2; OVOL2;	GO:0071560~cellular response to transforming growth factor beta stimulus	7	56	12.5	0.0103303998871426	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	MT1X; MT1A; MT1G; MT1M; SLC39A4;	GO:0006882~cellular zinc ion homeostasis	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	HAP1; VAMP2; LGI3; RAB10; RAB13;	GO:0017157~regulation of exocytosis	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	DVL1; PIGR; PTN; LRRC1; DLG3;	GO:0043113~receptor clustering	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	TXN; NME1; FOXC1; TRIM28; HES1;	GO:0043388~positive regulation of DNA binding	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	ID1; NEK2; MDFI; SMO; CTNNBIP1;	GO:0043392~negative regulation of DNA binding	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	EGFR; GJA1; ADRA2C; TRPM4; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
down	MATN2; APOD; CDK1; ARF4; TXN2;	GO:0048678~response to axon injury	5	30	16.6666666666667	0.0103311976993019	0.0726152573922197	1	1	0.971805032669432	0.999999349769181	0.658814584316526
up	TLR2; TIMP1; CCL3; TLR1; TLR6;	GO:0001775~cell activation	5	10	50	0.0104735174157922	0.427185428564157	1	1	1	1	1
up	TLR4; IL18RAP; EOMES; ITK; LILRB1;	GO:0032609~interferon-gamma production	5	10	50	0.0104735174157922	0.427185428564157	1	1	1	1	1
up	TLR4; IFNG; IL4; IL10; TMEM106A;	GO:0045348~positive regulation of MHC class II biosynthetic process	5	10	50	0.0104735174157922	0.427185428564157	1	1	1	1	1
up	PTPN6; NFAM1; FCRL3; CARD11; IKZF3;	GO:0045577~regulation of B cell differentiation	5	10	50	0.0104735174157922	0.427185428564157	1	1	1	1	1
down	NR1D1; GYS2; NHLRC1; PGM2;	GO:0005978~glycogen biosynthetic process	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	MAPK13; EGFR; MAP7; MARVELD3;	GO:0006970~response to osmotic stress	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	DDAH1; APOE; MT1M; NDNF;	GO:0007263~nitric oxide mediated signal transduction	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	DLX3; DLX5; DLG3; LRRC1;	GO:0009790~embryo development	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	PDGFRA; SRD5A1; DHCR24; LGR4;	GO:0030539~male genitalia development	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	ELOVL1; ELOVL4; ELOVL6; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	UNC13B; NTF4; GABRB2; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	ADCY6; P2RY2; FOXC1; ACE2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
down	HRAS; NTF3; TEK; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	4	19	21.0526315789474	0.0106963497178778	0.0742220465529904	1	1	0.975547542422973	0.999999349769181	0.673392459146876
up	TLR4; TLR2; SASH3; HGF; TNFSF4; CD40LG; FCER1G; TIGIT;	GO:0032733~positive regulation of interleukin-10 production	8	25	32	0.0107771417379724	0.427185428564157	1	1	1	1	1
down	DLX3; CEACAM1; GJA4; FOXF1; STRA6; APLNR;	GO:0001568~blood vessel development	6	43	13.953488372093	0.0108420658349884	0.0750203480406833	1	1	0.976856650772977	0.999999349769181	0.680635188590537
down	EGFR; ERBB2; GSTP1; ID1; FOXC1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	6	43	13.953488372093	0.0108420658349884	0.0750203480406833	1	1	0.976856650772977	0.999999349769181	0.680635188590537
up	TLR4; PLCL2; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0108560464692289	0.427185428564157	1	1	1	1	1
up	PTH; HMGA2; MAP3K3; LEF1;	GO:0071864~positive regulation of cell proliferation in bone marrow	4	6	66.6666666666667	0.0108560464692289	0.427185428564157	1	1	1	1	1
up	CCL3; CCL4; CCL5; CCL7;	GO:2000503~positive regulation of natural killer cell chemotaxis	4	6	66.6666666666667	0.0108560464692289	0.427185428564157	1	1	1	1	1
down	FZD6; TFAP2A; FGFR2; ALDH1A3; ITGA8; DLX5; USH1G;	GO:0042472~inner ear morphogenesis	7	57	12.280701754386	0.0112243653907499	0.077446538069885	1	1	0.980985377107604	0.999999349769181	0.702647220675308
down	EGFR; BMP4; ALOX12; FGFR2; CX3CL1; HES5; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	7	57	12.280701754386	0.0112243653907499	0.077446538069885	1	1	0.980985377107604	0.999999349769181	0.702647220675308
down	MEIS1; ASTN1; NPY1R; CHRNB4; ALDH1A3; SLURP1; NAV2; PAK6; PAK5;	GO:0007626~locomotory behavior	9	87	10.3448275862069	0.0115996957253047	0.0796575374281764	1	1	0.985444401549003	0.999999349769181	0.722706897876327
up	F2; ITGB3; PRKCB; LCK; GP1BA; F2R; PTPN6; CD40LG; FCER1G; ARRB2; GP5; PIK3CG; P2RX1; GNG2; GNA12; TRPC3; DGKK; TREML1; PIK3R5; CLEC1B;	GO:0030168~platelet activation	20	102	19.6078431372549	0.0116240949461942	0.451322571464045	1	1	1	1	1
down	SPRY1; GJA1; GPSM2; SAPCD2; MISP;	GO:0000132~establishment of mitotic spindle orientation	5	31	16.1290322580645	0.0116262227562792	0.0796575374281764	1	1	0.985444401549003	0.999999349769181	0.722706897876327
down	CA2; KRT14; S100A8; PLN; GGH;	GO:0010043~response to zinc ion	5	31	16.1290322580645	0.0116262227562792	0.0796575374281764	1	1	0.985444401549003	0.999999349769181	0.722706897876327
down	FOXP2; NME1; PLN; PSPH; BAD;	GO:0033574~response to testosterone	5	31	16.1290322580645	0.0116262227562792	0.0796575374281764	1	1	0.985444401549003	0.999999349769181	0.722706897876327
down	EGFR; SRD5A1; GJB2; AQP1; EIF4EBP1;	GO:0071549~cellular response to dexamethasone stimulus	5	31	16.1290322580645	0.0116262227562792	0.0796575374281764	1	1	0.985444401549003	0.999999349769181	0.722706897876327
down	DVL1; HSPB1; GSTP1; CEACAM1; SFN; AKT1S1; TRIB3; WWTR1;	GO:0006469~negative regulation of protein kinase activity	8	72	11.1111111111111	0.0116986390656397	0.0799298076942871	1	1	0.985444401549003	0.999999349769181	0.72517711734027
down	ANXA1; CX3CL1; CCL17; CCL21; CCL19; CCL11;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.0119299022115343	0.0804533628800926	1	1	0.988620692931916	0.999999349769181	0.729927163053668
down	PDGFRA; CD24; SLURP1;	GO:0001775~cell activation	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	BMP4; FGFR2; FZD1;	GO:0003149~membranous septum morphogenesis	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	EGFR; FOXF1; SMO;	GO:0007494~midgut development	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	CLTA; AP2S1; VLDLR;	GO:0032802~low-density lipoprotein particle receptor catabolic process	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	FGFR3; STC1; IHH;	GO:0035988~chondrocyte proliferation	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	CEACAM1; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	PSEN2; DHCR24; APH1A;	GO:0042987~amyloid precursor protein catabolic process	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	DDR1; SHROOM2; STRA6;	GO:0043583~ear development	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	IGFBP4; SERPINB1; BAD;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	TGFA; ADRA2A; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	GCKR; SLC16A9; ABCG2;	GO:0046415~urate metabolic process	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	EGFR; RTP1; REEP1;	GO:0051205~protein insertion into membrane	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	BMP4; BMP7; HYAL1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	HSPA1B; DNAJB1; HSPA2;	GO:0090084~negative regulation of inclusion body assembly	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	ITPKA; CTTN; TANC1;	GO:0097062~dendritic spine maintenance	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	LYNX1; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	ZNF205; CHCHD10; BOK;	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	HSPB1; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	3	10	30	0.0121041854210442	0.0804533628800926	1	1	0.990275011360517	0.999999349769181	0.729927163053668
down	BMP7; LUM; PITX1; HYAL1; HYAL2; SMAD1; HES5;	GO:0051216~cartilage development	7	58	12.0689655172414	0.012173011487583	0.0808010477574708	1	1	0.990275011360517	0.999999349769181	0.733081594728072
down	BCAR1; EIF4EBP1; ATP6V1F; ATP6V1C2; RARRES2; ATP6V0A4; BAIAP2; ATP6V1D; GRB7;	GO:0008286~insulin receptor signaling pathway	9	88	10.2272727272727	0.0123628553506073	0.0817680280743173	1	1	0.991975930308234	0.999999349769181	0.741854692261068
down	GSTP1; GAS6; CCDC3; TRAIP;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	BMP4; RARG; EFEMP1; CHADL;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	RPS6KA4; SYT14P1; ADGRF1; LPAR5;	GO:0032793~positive regulation of CREB transcription factor activity	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	YES1; PTN; HYAL1; CORO1B;	GO:0036120~cellular response to platelet-derived growth factor stimulus	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	SYNGR1; RAB10; ABCA12; TMEM79;	GO:0045055~regulated exocytosis	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	FOXN1; ID1; SLC1A1; EFNB2;	GO:0048514~blood vessel morphogenesis	4	20	20	0.0124524082001976	0.0817680280743173	1	1	0.993725446940171	0.999999349769181	0.741854692261068
down	BIRC5; SLC25A5; NEK2; CENPW; CDT1; SPC25; TTK; CENPH;	GO:0007059~chromosome segregation	8	73	10.958904109589	0.0125559185277275	0.0818381203957157	1	1	0.993725446940171	0.999999349769181	0.742490617068666
down	SLC6A15; SLC6A14; SLC6A9; CNNM1; SLC6A11;	GO:0006810~transport	5	32	15.625	0.0130272788760339	0.0818381203957157	1	1	0.999287343098418	0.999999349769181	0.742490617068666
down	TJP1; CNN3; EPB41L4B; EPB41L1; FRMD6;	GO:0031032~actomyosin structure organization	5	32	15.625	0.0130272788760339	0.0818381203957157	1	1	0.999287343098418	0.999999349769181	0.742490617068666
down	GABRB2; HOXA1; HES1; SLITRK6; HEY2;	GO:0090102~cochlea development	5	32	15.625	0.0130272788760339	0.0818381203957157	1	1	0.999287343098418	0.999999349769181	0.742490617068666
down	TP73; SFN; BAD; BCL2L10; BCL2L2; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	6	45	13.3333333333333	0.0130922851519848	0.0818381203957157	1	1	0.999287343098418	0.999999349769181	0.742490617068666
down	GPR37; ADCY6; ADRA2A; NPY1R; GNAI1; ADCY2; PSAPL1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	7	59	11.864406779661	0.0131780825695293	0.0818381203957157	1	1	0.999999349769181	0.999999349769181	0.742490617068666
down	GJA1; ID4; DUOXA1; DUOXA2; AJUBA; FRMD6; GAS8;	GO:0034613~cellular protein localization	7	59	11.864406779661	0.0131780825695293	0.0818381203957157	1	1	0.999999349769181	0.999999349769181	0.742490617068666
down	BMP2; BMP4; BMP7; HNF4A; SMAD1; ATOH8; INHA;	GO:0060395~SMAD protein signal transduction	7	59	11.864406779661	0.0131780825695293	0.0818381203957157	1	1	0.999999349769181	0.999999349769181	0.742490617068666
up	TLR4; TLR2; CD14; CD36; BTK; TLR1; TLR8; TLR6; LY96;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	9	32	28.125	0.0136442009814784	0.489147016712145	1	1	1	1	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	PIK3CD; MPO; PIK3CG;	GO:0002679~respiratory burst involved in defense response	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	TLR2; CD14; TLR1;	GO:0071727~cellular response to triacyl bacterial lipopeptide	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	TYROBP; ITGAM; STAP1;	GO:1904151~positive regulation of microglial cell mediated cytotoxicity	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0139223547323406	0.489147016712145	1	1	1	1	1
down	DAD1; TUSC3; DOLPP1; GORASP1; MGAT4B; B3GALNT1;	GO:0006487~protein N-linked glycosylation	6	46	13.0434782608696	0.0143316222693424	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	CDK1; G6PD; COMT; EIF4A3; LUM; TXN2;	GO:0014070~response to organic cyclic compound	6	46	13.0434782608696	0.0143316222693424	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	MYO1D; DNAJB1; SSTR1; SOX2; POU3F1; NOTCH3;	GO:0030900~forebrain development	6	46	13.0434782608696	0.0143316222693424	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	LRAT; RARG; GJA1; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.0143316222693424	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	ADRA2A; GHR; IGFBP2; RAMP2; RAMP3; AVPR1A;	GO:0032870~cellular response to hormone stimulus	6	46	13.0434782608696	0.0143316222693424	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	KDR; EFNB2; CLEC14A; MMRN2;	GO:0002042~cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.014382384116326	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	TCN1; PRSS3; MMAB; AMN;	GO:0009235~cobalamin metabolic process	4	21	19.047619047619	0.014382384116326	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	CHMP4C; MVB12A; CHMP1A; CHMP3;	GO:0039702~viral budding via host ESCRT complex	4	21	19.047619047619	0.014382384116326	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	MT-ATP6; MT-ATP8; COX5B; CYC1;	GO:0042776~mitochondrial ATP synthesis coupled proton transport	4	21	19.047619047619	0.014382384116326	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	NOL3; LMNA; BCL2L2; HIGD1A;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	4	21	19.047619047619	0.014382384116326	0.085283179511596	1	1	0.999999349769181	0.999999349769181	0.773746516598366
down	ACHE; SLC44A4; SLC44A3; PEMT; STARD10;	GO:0006656~phosphatidylcholine biosynthetic process	5	33	15.1515151515152	0.0145379428713041	0.0857896459908558	1	1	0.999999349769181	0.999999349769181	0.778341522041941
down	ERBB2; ERBB3; C1QBP; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.0145379428713041	0.0857896459908558	1	1	0.999999349769181	0.999999349769181	0.778341522041941
down	RHOD; RAC1; AJUBA; ARHGEF4; ABLIM2;	GO:0030032~lamellipodium assembly	5	33	15.1515151515152	0.0145379428713041	0.0857896459908558	1	1	0.999999349769181	0.999999349769181	0.778341522041941
down	TFAP2A; HOXD9; CRABP2; TP63; ZNF358;	GO:0035115~embryonic forelimb morphogenesis	5	33	15.1515151515152	0.0145379428713041	0.0857896459908558	1	1	0.999999349769181	0.999999349769181	0.778341522041941
down	S100A8; S100A9; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	SERPINB3; ADRM1; SFRP2;	GO:0010950~positive regulation of endopeptidase activity	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	P4HB; PRDX4; EGLN3;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	EFNA5; EPHB3; WNT4;	GO:0022407~regulation of cell-cell adhesion	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	MGST1; PDGFRA; CCND1;	GO:0033327~Leydig cell differentiation	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	CDK1; AURKB; TTK;	GO:0034501~protein localization to kinetochore	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	PTN; MESP1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	BMP4; ATOH8; TMEM100;	GO:0045603~positive regulation of endothelial cell differentiation	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	KLK8; RGMA; KREMEN1;	GO:0048681~negative regulation of axon regeneration	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	BMP7; FGFR2; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	EFNB2; CPT1C; DLG3;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	3	11	27.2727272727273	0.0149712426907956	0.0871896657659194	1	1	0.999999349769181	0.999999349769181	0.791043445566931
down	ADCY6; TBX6; APOE; EFNB2; INPP5J; ZNF365; TRPV4;	GO:0010977~negative regulation of neuron projection development	7	61	11.4754098360656	0.0153643379211263	0.0892664383730999	1	1	0.999999349769181	0.999999349769181	0.809885327163926
up	CD4; LCK; HCK; CD8B; CD247; AP1S2; ELMO1; DOCK2;	GO:0050690~regulation of defense response to virus by virus	8	27	29.6296296296296	0.0154039356491728	0.529474474468815	1	1	1	1	1
down	CEACAM5; CEACAM6; LGALS7; CXADR; NECTIN1; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	6	47	12.7659574468085	0.0156502510557812	0.0906047670590316	1	1	0.999999349769181	0.999999349769181	0.822027547525945
down	ITPKA; INPP1; PLCD1; INPP5J; PLCD3; IPPK;	GO:0043647~inositol phosphate metabolic process	6	47	12.7659574468085	0.0156502510557812	0.0906047670590316	1	1	0.999999349769181	0.999999349769181	0.822027547525945
up	PTPRC; STAT5B; NCKAP1L; LEF1;	GO:0045588~positive regulation of gamma-delta T cell differentiation	4	7	57.1428571428571	0.0157857930615897	0.529474474468815	1	1	1	1	1
up	RARA; TNFSF4; CD86; NLRP3;	GO:0045630~positive regulation of T-helper 2 cell differentiation	4	7	57.1428571428571	0.0157857930615897	0.529474474468815	1	1	1	1	1
up	DOK2; CD4; CD8A; CD3E; CD7; CD8B; TRAT1; IL31RA; RASGRP4; DOK1; STAP1; SH2B3; SLA; NEDD9; FGR; FES; HCK; EPHB1; BLK; FLT3; LCK; SHC4;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	22	120	18.3333333333333	0.0158775064770826	0.529474474468815	1	1	1	1	1
down	DVL1; LMNA; BMP4; BMP7; SMO;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.0161616094301131	0.0931243737716295	1	1	0.999999349769181	0.999999349769181	0.844887118759512
down	SCD; TM7SF2; FDPS; PMVK; ELOVL6;	GO:0045540~regulation of cholesterol biosynthetic process	5	34	14.7058823529412	0.0161616094301131	0.0931243737716295	1	1	0.999999349769181	0.999999349769181	0.844887118759512
down	DVL1; RBFOX2; MAP2; VLDLR; PREX2;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.0161616094301131	0.0931243737716295	1	1	0.999999349769181	0.999999349769181	0.844887118759512
down	NEK2; GRHL2; PARM1; AURKB; PKIB;	GO:0051973~positive regulation of telomerase activity	5	34	14.7058823529412	0.0161616094301131	0.0931243737716295	1	1	0.999999349769181	0.999999349769181	0.844887118759512
down	DVL1; SLPI; RALB; ID1; CARD18; AURKB; CTNNBIP1; CCM2L;	GO:0032091~negative regulation of protein binding	8	77	10.3896103896104	0.0164492051537694	0.0944685805375222	1	1	0.999999349769181	0.999999349769181	0.857082669026913
down	GGCT; SFN; BOK; BAD;	GO:0001836~release of cytochrome c from mitochondria	4	22	18.1818181818182	0.0164914488509902	0.0944685805375222	1	1	0.999999349769181	0.999999349769181	0.857082669026913
down	SLC9A3R1; RARG; KEL; RAC1;	GO:0008361~regulation of cell size	4	22	18.1818181818182	0.0164914488509902	0.0944685805375222	1	1	0.999999349769181	0.999999349769181	0.857082669026913
down	ARF4; DLG3; PARD3; LRRC1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	4	22	18.1818181818182	0.0164914488509902	0.0944685805375222	1	1	0.999999349769181	0.999999349769181	0.857082669026913
down	KALRN; ITPKA; BAIAP2; CTTN;	GO:0061003~positive regulation of dendritic spine morphogenesis	4	22	18.1818181818182	0.0164914488509902	0.0944685805375222	1	1	0.999999349769181	0.999999349769181	0.857082669026913
down	CLDN5; ARF4; PTN; COMT; STRA6; PAK6; PAK5;	GO:0007612~learning	7	62	11.2903225806452	0.0165488612805237	0.0945759689069181	1	1	0.999999349769181	0.999999349769181	0.858056968733128
down	KLK8; SLC1A3; SOX2; RAC1; KLK6; TMPRSS4; PLLP;	GO:0009611~response to wounding	7	62	11.2903225806452	0.0165488612805237	0.0945759689069181	1	1	0.999999349769181	0.999999349769181	0.858056968733128
up	PIK3CD; LCK; THBS1; CSF3; CCL3; OSM; HGF; HCLS1; RAC2; ENG; GATA3; ARRB2; CCR7; CD80; THPO; CD86; PIK3CG; CX3CR1; ADAM8; PTPRJ; TRAT1; PIK3AP1; PIK3R5; RASD2; P2RX4; C1QTNF1; FGF23; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	28	165	16.969696969697	0.0168935850754841	0.558624010689327	1	1	1	1	1
down	KALRN; CSTB; HOXD9; NTF4; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	6	48	12.5	0.0170504331511255	0.0969892081108211	1	1	0.999999349769181	0.999999349769181	0.879951502197194
down	BMP2; BMP4; BMP7; TTK; HFE; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	6	48	12.5	0.0170504331511255	0.0969892081108211	1	1	0.999999349769181	0.999999349769181	0.879951502197194
down	FOXP2; PTN; SSTR1; FCGR2B; HAP1; FOXC1;	GO:0021549~cerebellum development	6	48	12.5	0.0170504331511255	0.0969892081108211	1	1	0.999999349769181	0.999999349769181	0.879951502197194
down	DEFB4A; ROMO1; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	5	35	14.2857142857143	0.0179014819220887	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	NUPR1; FGFR2; TGM1; CCND1; PTK6;	GO:0045787~positive regulation of cell cycle	5	35	14.2857142857143	0.0179014819220887	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	HSPA1B; PRDX2; CX3CL1; UNC5B; EYA2;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	35	14.2857142857143	0.0179014819220887	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	AK4; SLC25A23; COX7A2;	GO:0002082~regulation of oxidative phosphorylation	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	MEIS1; SHROOM2; NECTIN1;	GO:0002089~lens morphogenesis in camera-type eye	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	BMP4; HNF4A; SMO;	GO:0003323~type B pancreatic cell development	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	G6PD; PGD; PGM2;	GO:0006098~pentose-phosphate shunt	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	FBXO27; FBXO17; NCCRP1;	GO:0006516~glycoprotein catabolic process	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	ALDH7A1; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	CCNB2; CDK1; CCNB1;	GO:0007077~mitotic nuclear envelope disassembly	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	APOE; USP6NL; RAB1B;	GO:0019068~virion assembly	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	SERPINB4; LTBP4; SERPINB13;	GO:0030162~regulation of proteolysis	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	RARG; ALDH1A3; PPP1R13L;	GO:0031076~embryonic camera-type eye development	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	WNT7B; SMAD1; RHCG;	GO:0042592~homeostatic process	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	ABCC3; SLC2A1; EBP;	GO:0042908~xenobiotic transport	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	BMP2; BMP4; PTN;	GO:0045778~positive regulation of ossification	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	TLCD2; HNF4A; TLCD1;	GO:0055091~phospholipid homeostasis	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	CACNB3; TRPM1; JPH1;	GO:0060402~calcium ion transport into cytosol	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	CEACAM1; ALOX12; CD9;	GO:0090331~negative regulation of platelet aggregation	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	GIPC1; P4HB; HDGF;	GO:0098761~cellular response to interleukin-7	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	UBE2C; CDC20; GORASP1;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	SPINT2; TACSTD2; FBLN1;	GO:2000146~negative regulation of cell motility	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
down	MT-CO2; ENO1; TREM2;	GO:2001171~positive regulation of ATP biosynthetic process	3	12	25	0.0181878623117704	0.100650477861064	1	1	0.999999349769181	0.999999349769181	0.913169010406915
up	TLR4; THBS1; IL10; IL13; IL1RL1; TLR6;	GO:0043032~positive regulation of macrophage activation	6	17	35.2941176470588	0.0182941149997637	0.591460352647509	1	1	1	1	1
up	PIK3CD; TOX; PTPRC; HNF1A; STAT5B;	GO:0001779~natural killer cell differentiation	5	12	41.6666666666667	0.0183762024279699	0.591460352647509	1	1	1	1	1
up	IL2RA; CTLA4; HLA-G; PDCD1; INPP5D;	GO:0050777~negative regulation of immune response	5	12	41.6666666666667	0.0183762024279699	0.591460352647509	1	1	1	1	1
up	PTPRC; MS4A1; CD79A; IL10; CD40LG; CD70; CARD11; LEF1; IFNA5;	GO:0042100~B cell proliferation	9	34	26.4705882352941	0.0184878331323109	0.591460352647509	1	1	1	1	1
down	C2CD4B; GSN; PRLR; FUT1; FUT2; SPINK5;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.0185343489547838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	GSN; BMP2; NR1D1; ID1; ISOC2; SOX17;	GO:0031648~protein destabilization	6	49	12.2448979591837	0.0185343489547838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	DVL1; KLK8; C1QA; WNT7B; PPFIA3; PPFIBP2;	GO:0050808~synapse organization	6	49	12.2448979591837	0.0185343489547838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	PROM1; TSPAN12; TFAP2A; TFAP2B;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	FABP12; FABP1; PNPLA4; MGLL;	GO:0019433~triglyceride catabolic process	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	RHOD; EFNA5; ACTG1; CAMSAP3;	GO:0051893~regulation of focal adhesion assembly	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	MMP7; DSG1; DSG2; IHH;	GO:0060135~maternal process involved in female pregnancy	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	MT-ND3; ANXA1; GSTP1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	HSPA1B; CHMP4C; CHMP1A; CHMP3;	GO:1901673~regulation of mitotic spindle assembly	4	23	17.3913043478261	0.0187841942980838	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	IDH1; MDH2; IDH2; FAHD1; MDH1B;	GO:0006099~tricarboxylic acid cycle	5	36	13.8888888888889	0.0197605643708131	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	MT-CO2; CXCL10; HSPA2; LRP11; ACOT11;	GO:0009409~response to cold	5	36	13.8888888888889	0.0197605643708131	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	PRSS16; PGC; BACE2; PGA5; CTSE;	GO:0030163~protein catabolic process	5	36	13.8888888888889	0.0197605643708131	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	EDN3; BTC; SOX2; PPP1R13L; SOX17;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.0197605643708131	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	CLDN5; ITGB5; CDH5; ID1; SMAD1; LTBP4; PARD3; CGN; BAMBI;	GO:0007179~transforming growth factor beta receptor signaling pathway	9	96	9.375	0.0198736165945987	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	DEFB4A; S100A7; DEFB1; ROMO1; LCE3A; NLRP10; IL22RA1; RARRES2;	GO:0050829~defense response to Gram-negative bacterium	8	80	10	0.0198914986014394	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	UBE2C; PSMD3; CDK1; CCNB1; PSMB6; PSMB5; PSMD8; CDC20;	GO:1901990~regulation of mitotic cell cycle phase transition	8	80	10	0.0198914986014394	0.101788942301453	1	1	0.999999349769181	0.999999349769181	0.923497927551731
down	BHLHE40; PRMT5; NR1D1; NPAS2; LGR4; ID4; ID1;	GO:0032922~circadian regulation of gene expression	7	65	10.7692307692308	0.0204872657627876	0.104508554860852	1	1	0.999999349769181	0.999999349769181	0.948172086704605
up	CCL24; SH2D1A; GRAP2; TSHB; GHRH; LTA; WNT1; ITGB2; INHBA; CCL3; PTHLH; CCL4; CCL5; CD33; TRH; CCR1; SSTR3; CD70; TNFSF8; CXCL5; PTGIR; FASLG; CX3CR1; CCR5; CCL7; CRB1; LTB; GRAP; LILRB2; FCRL2; TSPAN32; SIRPG; CCL26; PTH; ADRA1D; FGFBP2;	GO:0007267~cell-cell signaling	36	230	15.6521739130435	0.0209863497841152	0.632063961845663	1	1	1	1	1
down	CDC20; TRIP13; AURKB; TTK;	GO:0007094~mitotic spindle assembly checkpoint	4	24	16.6666666666667	0.0212646330352813	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	CX3CL1; CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0212646330352813	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	MEIS2; FOXF1; HES1; IHH;	GO:0031016~pancreas development	4	24	16.6666666666667	0.0212646330352813	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	CYP2E1; CYP2C9; ALOX12; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	4	24	16.6666666666667	0.0212646330352813	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
up	KCNN4; FCMR; CD300C; VSTM1; CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	9	35	25.7142857142857	0.0213288438252309	0.632063961845663	1	1	1	1	1
down	RPS6KA4; GPNMB; NDRG2;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	BMP4; TMEM100; HEY2;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	BMP4; PPP1R13L; HEY2;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	AKR1B15; DHRS11; HSD17B8;	GO:0006703~estrogen biosynthetic process	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	PRLR; EFNA5; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	ZBTB7B; KRT6B; GRHL3;	GO:0007398~ectoderm development	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	HRAS; PDGFRA; NTF3;	GO:0010863~positive regulation of phospholipase C activity	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	TUSC3; NIPAL1; NIPAL2;	GO:0015693~magnesium ion transport	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	APOE; TSPAN8; CD34;	GO:0030195~negative regulation of blood coagulation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	EPN2; CADM4; MMRN2;	GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	MAP2; CDH5; INPP5J;	GO:0031115~negative regulation of microtubule polymerization	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	CAPN1; LGMN; MVB12A;	GO:0032801~receptor catabolic process	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	CEACAM1; ACADL; TRIB3;	GO:0045717~negative regulation of fatty acid biosynthetic process	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	AK4; AK8; AK3;	GO:0046940~nucleoside monophosphate phosphorylation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	WNT4; FOXF1; HEY2;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	GABRB2; GABRA4; GABRE;	GO:0051932~synaptic transmission, GABAergic	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	BMP2; ADAM15; HEY2;	GO:0060317~cardiac epithelial to mesenchymal transition	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	BMP4; ID1; WNT7B;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	CCL11; DDR1; LRP5;	GO:0060444~branching involved in mammary gland duct morphogenesis	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	IRF6; PRLR; SMO;	GO:0060644~mammary gland epithelial cell differentiation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	E2F8; HNF4A; ANXA1;	GO:0070365~hepatocyte differentiation	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	HES1; HES5; PARD3;	GO:0090162~establishment of epithelial cell polarity	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	DVL1; EFNB2; FZD1;	GO:0099054~presynapse assembly	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	TACSTD2; FBLN1; EFNA5;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	3	13	23.0769230769231	0.0217570048113727	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
down	MAPK13; PTN; AQP1; AURKB; PBK; RUVBL2;	GO:0034644~cellular response to UV	6	51	11.7647058823529	0.0217616672259056	0.107751089138796	1	1	0.999999349769181	0.999999349769181	0.977590544328697
up	CD160; HLA-G; HLA-F; KIR2DL4;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.0219176257032485	0.632063961845663	1	1	1	1	1
up	IL4; RARA; TNFSF4; NLRP3;	GO:0032736~positive regulation of interleukin-13 production	4	8	50	0.0219176257032485	0.632063961845663	1	1	1	1	1
up	PRTN3; F2R; MYADM; PARD6A;	GO:0045217~cell-cell junction maintenance	4	8	50	0.0219176257032485	0.632063961845663	1	1	1	1	1
up	PRKCB; NFAM1; CMTM3; STAP1;	GO:0050861~positive regulation of B cell receptor signaling pathway	4	8	50	0.0219176257032485	0.632063961845663	1	1	1	1	1
up	PTH; PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	4	8	50	0.0219176257032485	0.632063961845663	1	1	1	1	1
down	CHP2; RASAL1; RYR1; ENDOG; ACER1; LGMN; SLC25A23; SYT8;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.0224530422584759	0.111061964336162	1	1	0.999999349769181	0.999999349769181	1
up	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	TNFRSF1B; CCR2; CLC;	GO:0002724~regulation of T cell cytokine production	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	TLR4; PLEK; SELP;	GO:0010572~positive regulation of platelet activation	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	CD22; MZB1; IKZF3;	GO:0030888~regulation of B cell proliferation	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	IFI30; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	TLR2; TLR1; TLR6;	GO:0071221~cellular response to bacterial lipopeptide	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0226482893571127	0.632063961845663	1	1	1	1	1
down	EYA2; PTPRF; PTPRZ1; PTPN13; CDKN3; PTPN21; SSH3; DUSP13; PTPRQ;	GO:0035335~peptidyl-tyrosine dephosphorylation	9	99	9.09090909090909	0.0233977869572948	0.115501487179703	1	1	0.999999349769181	0.999999349769181	1
up	CRYBA1; IL10; SLC11A1; BTK; CLEC4A;	GO:0001818~negative regulation of cytokine production	5	13	38.4615384615385	0.0234873035780179	0.641823191524308	1	1	1	1	1
up	CD27; STAT5B; NCKAP1L; BTK; INPP5D;	GO:0045579~positive regulation of B cell differentiation	5	13	38.4615384615385	0.0234873035780179	0.641823191524308	1	1	1	1	1
up	CRTAM; CD2; CCR2; CARD11; TBX21;	GO:0045580~regulation of T cell differentiation	5	13	38.4615384615385	0.0234873035780179	0.641823191524308	1	1	1	1	1
down	HSPA4L; HSPB1; DNAJB1; HSPE1; HSPA2; HSPA1B;	GO:0006986~response to unfolded protein	6	52	11.5384615384615	0.02350898075858	0.115816650423941	1	1	0.999999349769181	0.999999349769181	1
down	SORBS3; ARHGEF15; RAPGEF3; WNT4; S100A10; RAC1;	GO:0051496~positive regulation of stress fiber assembly	6	52	11.5384615384615	0.02350898075858	0.115816650423941	1	1	0.999999349769181	0.999999349769181	1
down	RAB13; RAB10; SNX33; CHMP4C; MVB12A; VPS25; MYO5B; CHMP3;	GO:0016197~endosomal transport	8	83	9.63855421686747	0.0238172233015775	0.117217159347402	1	1	0.999999349769181	0.999999349769181	1
down	AGPAT2; ADRA2A; HILPDA; IL33;	GO:0001819~positive regulation of cytokine production	4	25	16	0.0239362020385554	0.117448245107937	1	1	0.999999349769181	0.999999349769181	1
down	SERPINB7; BMP4; WNT4; IHH;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.0239362020385554	0.117448245107937	1	1	0.999999349769181	0.999999349769181	1
down	MT1A; MT1G; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	4	25	16	0.0239362020385554	0.117448245107937	1	1	0.999999349769181	0.999999349769181	1
up	TLR4; LILRB3; FSTL3; IL4; CCL3; LILRB4; INPP5D;	GO:0045671~negative regulation of osteoclast differentiation	7	24	29.1666666666667	0.0243241544423395	0.660107225728316	1	1	1	1	1
down	GMNN; CCND1; CDKN2C; ID4; EIF4EBP1; CDKN3; CDT1; POLE3; PLK2;	GO:0000082~G1/S transition of mitotic cell cycle	9	100	9	0.0246656308989821	0.12090607851485	1	1	0.999999349769181	0.999999349769181	1
down	ERBB2; KEL; ADGRG6; KLK6; MAL2; PLLP;	GO:0042552~myelination	6	53	11.3207547169811	0.0253478418578892	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	GOT2; GOT1; AADAT;	GO:0006536~glutamate metabolic process	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	ID4; HES5; NKX6-2;	GO:0022010~central nervous system myelination	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	CCL21; RAC1; CORO1B;	GO:0031529~ruffle organization	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	"NAPRT; SLC5A8; NAXE;"	GO:0034356~NAD biosynthesis via nicotinamide riboside salvage pathway	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	BTC; HYAL2; TFAP2B;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	CD24; PPP1R14C; PPP1R14B;	GO:0042325~regulation of phosphorylation	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	NR1D1; HES1; PTPRQ;	GO:0045598~regulation of fat cell differentiation	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	CDK1; SOD3; S100A13;	GO:0046688~response to copper ion	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	SAA1; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	SCNN1A; SCNN1B; SCNN1G;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	SLC9A3R1; GNA14; GNA11;	GO:0060158~phospholipase C-activating dopamine receptor signaling pathway	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	PAK4; ARF4; EPHB3;	GO:0060996~dendritic spine development	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	ATP1B1; GJA1; GJD3;	GO:0086064~cell communication by electrical coupling involved in cardiac conduction	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	CLDN1; TJP1; RAB1B;	GO:0090557~establishment of endothelial intestinal barrier	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.0256795850314699	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	RGS12; RGS5; ERBB3; PTK6; RGS9BP;	GO:0009968~negative regulation of signal transduction	5	39	12.8205128205128	0.0260799843517729	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	HSPB1; ALOX12; KDR; ANGPT1; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	5	39	12.8205128205128	0.0260799843517729	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	EFNA1; ERBB3; CD24; GAS6; DLG3;	GO:0061098~positive regulation of protein tyrosine kinase activity	5	39	12.8205128205128	0.0260799843517729	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	FOXP2; SLC2A1; SRD5A1; BAD; SMO; GNG12; TACC2;	GO:0021987~cerebral cortex development	7	69	10.1449275362319	0.0266922063126899	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	GHR; FGFR3; PTK6; HES1; CTF1; HES5; STAP2;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	7	69	10.1449275362319	0.0266922063126899	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	PLPP3; KIF1C; ARF4; KDELR2; KIF2C; RAB1B; TMED3; ATP9A;	GO:0006890~retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum	8	85	9.41176470588235	0.0267177870319756	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	AVPR1A; RCAN2; TRPM4; CALML6; CALML5; CALML3; ACKR2; CXCR1;	GO:0019722~calcium-mediated signaling	8	85	9.41176470588235	0.0267177870319756	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	APOE; LYNX1; NQO1; CHRNB4;	GO:0007271~synaptic transmission, cholinergic	4	26	15.3846153846154	0.0268017695137075	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	RASAL1; TIMP2; PPP2CB; SPRY1;	GO:0046580~negative regulation of Ras protein signal transduction	4	26	15.3846153846154	0.0268017695137075	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	FZD7; FOLR1; KREMEN1; SOX7;	GO:0060828~regulation of canonical Wnt signaling pathway	4	26	15.3846153846154	0.0268017695137075	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	CCL21; RAC1; C1QBP; CCL19;	GO:0090023~positive regulation of neutrophil chemotaxis	4	26	15.3846153846154	0.0268017695137075	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
down	TP73; SFN; BAD; TP63;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	4	26	15.3846153846154	0.0268017695137075	0.123102780950224	1	1	0.999999349769181	0.999999349769181	1
up	TYROBP; GNAI2; ITGB2; ITGAM; CYBA; FPR2;	GO:0032930~positive regulation of superoxide anion generation	6	19	31.5789473684211	0.0272412750585573	0.72921372350628	1	1	1	1	1
up	CD160; THBS1; CCL2; HLA-G; CD40LG; FASLG;	GO:2000353~positive regulation of endothelial cell apoptotic process	6	19	31.5789473684211	0.0272412750585573	0.72921372350628	1	1	1	1	1
down	RAPGEF3; SRD5A1; AQP1; STC1; SLC5A5; HCN2;	GO:0071320~cellular response to cAMP	6	54	11.1111111111111	0.0272799563745399	0.123339691852356	1	1	0.999999349769181	0.999999349769181	1
up	LILRA5; TLR4; TLR2; IFNG; F2R; AIF1; IL16; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	9	37	24.3243243243243	0.0279261660952642	0.74249637557341	1	1	1	1	1
down	NUPR1; HSPB1; KEAP1; PIP4K2C; TRIB3; BOK; TMEM150C;	GO:0010506~regulation of autophagy	7	70	10	0.0284229611576757	0.128355164966719	1	1	0.999999349769181	0.999999349769181	1
down	ERBB3; ATN1; FAM162A; TP63; BOK;	GO:0051402~neuron apoptotic process	5	40	12.5	0.0284417413785616	0.128355164966719	1	1	0.999999349769181	0.999999349769181	1
up	CCDC88B; SLC11A1; NFAM1; TMIGD2; IL21; HHLA2; TNFSF4;	GO:0001819~positive regulation of cytokine production	7	25	28	0.0286447595074985	0.75204306193492	1	1	1	1	1
down	NKX2-8; HOXD9; POLR2I; MLF1; POLR2L; ABLIM2; PPP1R13L; ZNF219; LZTS1;	GO:0006351~transcription, DNA-templated	9	103	8.7378640776699	0.0287604759920318	0.129673961800018	1	1	0.999999349769181	0.999999349769181	1
down	LRP5; BMP4; IHH; GRHL2; SFRP2; INTU;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.0293069241096886	0.132016089083422	1	1	0.999999349769181	0.999999349769181	1
up	CCR2; IL12RB1; SLC11A1; IL27RA;	GO:0002827~positive regulation of T-helper 1 type immune response	4	9	44.4444444444444	0.0293135310680056	0.75204306193492	1	1	1	1	1
up	ITGB3; S1PR1; PDK4; SIGLEC15;	GO:0045124~regulation of bone resorption	4	9	44.4444444444444	0.0293135310680056	0.75204306193492	1	1	1	1	1
up	CRTAM; CD4; CCL5; SIT1;	GO:0050863~regulation of T cell activation	4	9	44.4444444444444	0.0293135310680056	0.75204306193492	1	1	1	1	1
up	TLR4; CD36; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	4	9	44.4444444444444	0.0293135310680056	0.75204306193492	1	1	1	1	1
up	PTH; CD33; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	5	14	35.7142857142857	0.0294319266932599	0.75204306193492	1	1	1	1	1
down	PDGFRA; NTF3; ERBB3; KDR; TEK; ANGPT1; UNC5B; ROR1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	8	87	9.19540229885057	0.0298547513433475	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	OSBPL6; HSD3B7; CYP39A1; AMACR;	GO:0006699~bile acid biosynthetic process	4	27	14.8148148148148	0.0298636444532889	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	MT-ATP6; MT-ATP8; ALDOA; UQCC3;	GO:0006754~ATP biosynthetic process	4	27	14.8148148148148	0.0298636444532889	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	CDH5; PLEKHA7; CDH17; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.0298636444532889	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	GJB6; NQO1; EEF1A2; S100A13;	GO:0051602~response to electrical stimulus	4	27	14.8148148148148	0.0298636444532889	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	ALDOA; ENO1; GPI; TPI1;	GO:0061621~canonical glycolysis	4	27	14.8148148148148	0.0298636444532889	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	BMP4; STRA6; HEY2;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	CXCL17; RARRES2; TRPV4;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	SPINT2; CDH1; MUC21;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	MUC13; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	RHOV; RHOJ; RAC1;	GO:0030865~cortical cytoskeleton organization	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	SOX18; FOXC1; SOX17;	GO:0035050~embryonic heart tube development	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	BMP7; FOXF2; IHH;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	PTTG1; CDCA8; CENPW;	GO:0051276~chromosome organization	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	IHH; FRZB; SMO;	GO:0061053~somite development	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	FIBIN; PLVAP; ADGRG1;	GO:0070528~protein kinase C signaling	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	BAD; PERP; LGMN;	GO:0097202~activation of cysteine-type endopeptidase activity	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	3	15	20	0.029954674626703	0.132733938653832	1	1	0.999999349769181	0.999999349769181	1
down	NUPR1; CDH1; NQO1; CYP2F1; MPST; SLC7A8; SLC6A14;	GO:0009636~response to toxic substance	7	71	9.85915492957746	0.0302280386150821	0.133703042409567	1	1	0.999999349769181	0.999999349769181	1
down	PSMD3; PSMB6; PSMB5; PSMD8; EPAS1; EGLN3; HIGD1A;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	7	71	9.85915492957746	0.0302280386150821	0.133703042409567	1	1	0.999999349769181	0.999999349769181	1
down	KIF20A; RAB11A; KLHL13; PLK2; AURKB;	GO:0032465~regulation of cytokinesis	5	41	12.1951219512195	0.0309345344987735	0.13645783838413	1	1	0.999999349769181	0.999999349769181	1
down	GJA1; FCGR2B; BCL2L2; LGMN; TREM2;	GO:1904646~cellular response to amyloid-beta	5	41	12.1951219512195	0.0309345344987735	0.13645783838413	1	1	0.999999349769181	0.999999349769181	1
down	APOD; G6PD; AKR1A1; NPY1R; TFAP2B; PGM2;	GO:0006006~glucose metabolic process	6	56	10.7142857142857	0.0314302359435628	0.138270426471141	1	1	0.999999349769181	0.999999349769181	1
down	E2F8; CDK1; CCNB1; SFN; TNKS1BP1; PLK2;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	6	56	10.7142857142857	0.0314302359435628	0.138270426471141	1	1	0.999999349769181	0.999999349769181	1
down	ANXA1; PDLIM4; CXADR; CTTN; TRPV4; PARVA;	GO:0031532~actin cytoskeleton reorganization	6	56	10.7142857142857	0.0314302359435628	0.138270426471141	1	1	0.999999349769181	0.999999349769181	1
down	CLUH; RAB38; CXADR; ADGRG6; CHCHD10; HSD17B10; EPAS1; ATAD3A;	GO:0007005~mitochondrion organization	8	88	9.09090909090909	0.0315143018539575	0.138515691527008	1	1	0.999999349769181	0.999999349769181	1
down	MPP2; KCTD11; KCTD1; KCTD14; KCNS3; PRMT8; KCTD5; KCNG1; KCTD3;	GO:0051260~protein homooligomerization	9	105	8.57142857142857	0.0317411940672729	0.139387721164362	1	1	0.999999349769181	0.999999349769181	1
up	TRPA1; ANXA6; SLC8A1; OPRM1; SLC8A3; TRPC3; CACNA1E; CACNA2D4; CATSPER1; SLC24A4; CACNG8; ATP2A3; ORAI1; ORAI2; P2RX4; TRPM6; PKD2L2; TRPC5; TRPV2; SLC24A5;	GO:0070588~calcium ion transmembrane transport	20	115	17.3913043478261	0.0318785002931893	0.781715889787239	1	1	1	1	1
down	LRP5; TXN; CCL11; FKBPL;	GO:0009314~response to radiation	4	28	14.2857142857143	0.0331235885631684	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	BMP4; RARG; PITX1; TP63;	GO:0035116~embryonic hindlimb morphogenesis	4	28	14.2857142857143	0.0331235885631684	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	NUPR1; GSTP1; PAWR; MED31;	GO:0048147~negative regulation of fibroblast proliferation	4	28	14.2857142857143	0.0331235885631684	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	S100A8; S100A9; NLRP10; IL17RC;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.0331235885631684	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	ZBTB42; CRYAB; CXCL10; ETV1; CTF1; ANKRD2; JPH1; COPRS;	GO:0007517~muscle organ development	8	89	8.98876404494382	0.0332357801912332	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	CLDN5; CXCL10; PTN; EFNA3; TEK; FOXC1; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0332357801912332	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
up	DYSF; RAC2; C5AR1; CXCR2; CCR7; NCKAP1L; C3AR1;	GO:0090023~positive regulation of neutrophil chemotaxis	7	26	26.9230769230769	0.033455271983941	0.781715889787239	1	1	1	1	1
down	BMP2; BMP4; WNT4; NPNT; CTNNBIP1;	GO:0001658~branching involved in ureteric bud morphogenesis	5	42	11.9047619047619	0.0335600637915179	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	RAMP2; RAMP3; CD9; ACHE; CXCR1;	GO:0031623~receptor internalization	5	42	11.9047619047619	0.0335600637915179	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	LYNX1; ADH7; HFE; LYPD6; DKK4;	GO:2000272~negative regulation of signaling receptor activity	5	42	11.9047619047619	0.0335600637915179	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	GSN; PDGFRA; ZP3; MUC5AC; PLCD1; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	6	57	10.5263157894737	0.0336512713179892	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	EGFR; SDC1; CCND1; AQP3; BAD; S100A16;	GO:0051592~response to calcium ion	6	57	10.5263157894737	0.0336512713179892	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
up	PTH; SSTR3; METTL21C;	GO:0008628~hormone-mediated apoptotic signaling pathway	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	PPT1; CAV3; MYADM;	GO:0031579~membrane raft organization	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	CTLA4; LAG3; TNFSF4;	GO:0045590~negative regulation of regulatory T cell differentiation	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	ITK; MICB; JAML;	GO:0046629~gamma-delta T cell activation	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	TOX; ADA; STAT5B;	GO:0048541~Peyer's patch development	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	CCL3; IL17RA; ADGRE2;	GO:0071621~granulocyte chemotaxis	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
up	CST7; CARD16; CARD8;	GO:0097340~inhibition of cysteine-type endopeptidase activity	3	5	60	0.0336992125057909	0.781715889787239	1	1	1	1	1
down	PLA2G4A; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	DLL4; CCM2L; HEY2;	GO:0003222~ventricular trabecula myocardium morphogenesis	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	PYGB; PHKA1; PGM2;	GO:0005980~glycogen catabolic process	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	PDLIM1; AQP1; RHOD;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	SPRY1; GPC1; WNT4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	MMP7; PTN; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	ALOX15B; FOXC1; OVOL2;	GO:0045618~positive regulation of keratinocyte differentiation	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	KLK6; KLK14; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	RARG; ESRRG; CYP26B1;	GO:0048384~retinoic acid receptor signaling pathway	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	SERPINB1; CARD18; CPTP;	GO:0050713~negative regulation of interleukin-1 beta secretion	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	MEIS1; TEK; MFAP5;	GO:0060216~definitive hemopoiesis	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	PRLR; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	NR1D1; EFNA5; LRP5;	GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	ACTG1; INA; CTTN;	GO:0098974~postsynaptic actin cytoskeleton organization	3	16	18.75	0.0345796901316463	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	ABO; FUT1; DAD1; FUT2; ST6GAL2; B3GNT6; B3GALNT1; B3GNT8;	GO:0006486~protein glycosylation	8	90	8.88888888888889	0.0350200493645842	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
down	TP73; SIK1; TTLL12; PAK5; CKS2; RPRM; PAK6; PAK4;	GO:0007346~regulation of mitotic cell cycle	8	90	8.88888888888889	0.0350200493645842	0.141778335216978	1	1	0.999999349769181	0.999999349769181	1
up	TLR4; IFNG; ITGB2; CD36; AIF1; HBB; P2RX4; TLR6; KLF2;	GO:0045429~positive regulation of nitric oxide biosynthetic process	9	39	23.0769230769231	0.035837020153909	0.781715889787239	1	1	1	1	1
down	HAP1; DHCR24; DUOXA1; DUOXA2; CCDC120; CBY1; PARD3;	GO:0008104~protein localization	7	74	9.45945945945946	0.0361004204232023	0.144638211883952	1	1	0.999999349769181	0.999999349769181	1
up	THBS1; CCL5; C5AR1; C3AR1; CMKLR1;	GO:0010759~positive regulation of macrophage chemotaxis	5	15	33.3333333333333	0.0362435616385584	0.781715889787239	1	1	1	1	1
down	ACADL; ECHS1; EHHADH; MCAT; CPT1C;	GO:0006635~fatty acid beta-oxidation	5	43	11.6279069767442	0.0363198032610486	0.145279213044194	1	1	0.999999349769181	0.999999349769181	1
down	G6PD; MAOB; DYNLL1; INA; NDRG2;	GO:0021762~substantia nigra development	5	43	11.6279069767442	0.0363198032610486	0.145279213044194	1	1	0.999999349769181	0.999999349769181	1
down	PRLR; FDXR; DHRS11; SRD5A1;	GO:0006694~steroid biosynthetic process	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	NPY1R; ADM2; MRAP2; STRA6;	GO:0007631~feeding behavior	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	RAB13; EPB41L1; LLGL2; NCKAP1;	GO:0030866~cortical actin cytoskeleton organization	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	UQCRQ; FGFR2; HES1; SMAD1;	GO:0030901~midbrain development	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	CX3CL1; GAS6; NLRX1; IL36RN;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	SLC9A3R1; EGFR; TIMP2; FOXC1;	GO:0045930~negative regulation of mitotic cell cycle	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	ERBB2; PTPRZ1; CDKN2C; BOK;	GO:0048709~oligodendrocyte differentiation	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
down	ADRA2C; COMT; MGLL; TMEM100;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.0365828302311297	0.145380345646374	1	1	0.999999349769181	0.999999349769181	1
up	CCL3; ADAM8; CCL26; CCL5; CCL4; CCL2; CCL24; CCL7;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.0376290696723146	0.781715889787239	1	1	1	1	1
up	SH2B2; F2; SERPINA1; IFNA5; SLC4A1; F11; ITGB3; GP1BA; ANXA5; F5; CD36; GATA2; GATA3; PRTN3; F2R; FCER1G; PRKAR2B; GP5; WAS; TFPI2; P2RX1; HBB; GNA12; NFE2; P2RX5; P2RX4; SH2B3;	GO:0007596~blood coagulation	27	171	15.7894736842105	0.0377048316247365	0.781715889787239	1	1	1	1	1
up	TESPA1; VNN1; ADA; ADAM8;	GO:0033089~positive regulation of T cell differentiation in thymus	4	10	40	0.0380110689723259	0.781715889787239	1	1	1	1	1
up	RAC2; TNFRSF1B; TNFSF8; IL27;	GO:0042129~regulation of T cell proliferation	4	10	40	0.0380110689723259	0.781715889787239	1	1	1	1	1
up	FGR; GATA2; FCER1G; IL13;	GO:0043306~positive regulation of mast cell degranulation	4	10	40	0.0380110689723259	0.781715889787239	1	1	1	1	1
up	PTPRC; HCK; FGR; OLFM4;	GO:0050764~regulation of phagocytosis	4	10	40	0.0380110689723259	0.781715889787239	1	1	1	1	1
up	TLR4; TLR2; CD14; CD36;	GO:0071223~cellular response to lipoteichoic acid	4	10	40	0.0380110689723259	0.781715889787239	1	1	1	1	1
down	PSMD3; ITGB5; PSMB6; PSMB5; PSMD8; VAMP8; CD207;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	7	75	9.33333333333333	0.0382136812079105	0.151738091289852	1	1	0.999999349769181	0.999999349769181	1
down	EGFR; S100B; GM2A; PTPRZ1; GATM; CCL11;	GO:0007611~learning or memory	6	59	10.1694915254237	0.0383914606025876	0.152196941059853	1	1	0.999999349769181	0.999999349769181	1
down	AGR2; HSPA1B; BMP4; BMP7; NPAS2; TMEM109;	GO:0060548~negative regulation of cell death	6	59	10.1694915254237	0.0383914606025876	0.152196941059853	1	1	0.999999349769181	0.999999349769181	1
up	CRTAM; IFNG; FGR; IL10; CLEC6A; CLEC4E; CD14;	GO:0050715~positive regulation of cytokine secretion	7	27	25.9259259259259	0.0387740391863485	0.781715889787239	1	1	1	1	1
down	RCAN2; PTPA; PPP4R1; PPP1R16A; PPP2R2C;	GO:0043666~regulation of phosphoprotein phosphatase activity	5	44	11.3636363636364	0.0392150006958132	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	CCNB2; PAX1; PRDX2; EPHB3; HES1;	GO:0048538~thymus development	5	44	11.3636363636364	0.0392150006958132	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	HOXB1; PDGFRA; MDFI; HOXD9; HOXA4;	GO:0048704~embryonic skeletal system morphogenesis	5	44	11.3636363636364	0.0392150006958132	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	RBFOX2; GM2A; SLC1A3; ALDH1A3; NKX6-2;	GO:0050885~neuromuscular process controlling balance	5	44	11.3636363636364	0.0392150006958132	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	EIF6; FBXW9; NHP2;	GO:0000470~maturation of LSU-rRNA	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	SCARA3; MATN2; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	AQP1; AQP5; AQP3;	GO:0006833~water transport	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	TSPAN15; RFNG; LLGL2;	GO:0008593~regulation of Notch signaling pathway	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	PIR; BMP4; MT1G;	GO:0030224~monocyte differentiation	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	G6PD; AKT1S1; EGLN3;	GO:0043523~regulation of neuron apoptotic process	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	SLC9A3R1; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	GJA1; LGR4; LRP5;	GO:0046849~bone remodeling	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	NOL3; CLDN1; BOK;	GO:0051259~protein complex oligomerization	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	CCND1; MAOB; AVPR1A;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	HES1; USH1G; HES5;	GO:0060122~inner ear receptor cell stereocilium organization	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	RARG; ALDH1A3; GRHL2;	GO:0060324~face development	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	BMP2; BMP4; SMAD1;	GO:0061036~positive regulation of cartilage development	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	CLDN18; TRIM29; TMEM98;	GO:1900181~negative regulation of protein localization to nucleus	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	NEK2; AURKB; PKIB;	GO:1904355~positive regulation of telomere capping	3	17	17.6470588235294	0.0395505674791599	0.154414506071868	1	1	0.999999349769181	0.999999349769181	1
down	OVOL1; TBX6; IRX3; MEST;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	TMPRSS11D; COX5B; ELN; SFTPA2;	GO:0007585~respiratory gaseous exchange by respiratory system	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	APOD; COMT; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	EPCAM; NELFB; ELL3; SOX21;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	PEX11A; MB; FFAR4; DIO2;	GO:0050873~brown fat cell differentiation	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	HRAS; CRYAB; YAP1; TMEM109;	GO:0071480~cellular response to gamma radiation	4	30	13.3333333333333	0.0402420802405694	0.15636557310315	1	1	0.999999349769181	0.999999349769181	1
down	UNC13B; GJB6; NME1; ENDOG; GAS6; AACS;	GO:0071333~cellular response to glucose stimulus	6	60	10	0.0409127984060413	0.158845563335202	1	1	0.999999349769181	0.999999349769181	1
down	NEURL1B; UBE2C; PEX10; CCNF; UBE2M; RAB40B; CDC20; TRIM28; KEAP1; KCTD11; TRAF7; NCCRP1; RNF128; CDCA3; EPAS1; TRAIP; RNF26; TRIM31; TRIM7; WWTR1; WSB2; KLHL13; FBXL7; CBLC; PDZRN3; MED31;	GO:0016567~protein ubiquitination	26	444	5.85585585585586	0.0418123249518203	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	ANXA2; LUM; FMOD; FOXC1; SFRP2;	GO:0030199~collagen fibril organization	5	45	11.1111111111111	0.0422466783051259	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	S100B; PTN; VAMP2; MPP2; PLK2;	GO:0060291~long-term synaptic potentiation	5	45	11.1111111111111	0.0422466783051259	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	GSTP1; CEACAM1; GOT1; SRD5A1; RAB13; RAB10; VAMP2; TRIB3;	GO:0032869~cellular response to insulin stimulus	8	94	8.51063829787234	0.0428008543693804	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
up	LCK; ALOX15; CD44; IL10; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	5	16	31.25	0.0439459496281396	0.781715889787239	1	1	1	1	1
up	CARD16; NLRP7; NLRP3; NLRC4; CARD8;	GO:0050713~negative regulation of interleukin-1 beta secretion	5	16	31.25	0.0439459496281396	0.781715889787239	1	1	1	1	1
down	APOE; GJA1; XDH; ATOH8;	GO:0001937~negative regulation of endothelial cell proliferation	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	ZWINT; HRAS; CDKN2B; PLK2;	GO:0007093~mitotic cell cycle checkpoint	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	MT-ATP6; MT-ATP8; UQCC3; APOOL;	GO:0042407~cristae formation	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	EGFR; CCNB1; CCND1; CKS2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	EGFR; TRIM28; NPAS2; EYA2;	GO:0045739~positive regulation of DNA repair	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	FGFR2; WNT7B; RARG; TEAD3;	GO:0048568~embryonic organ development	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	S100A8; S100A9; TJP1; CAPN6;	GO:0051493~regulation of cytoskeleton organization	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
down	MYO1C; HRAS; ERBB2; CACNB3;	GO:0090314~positive regulation of protein targeting to membrane	4	31	12.9032258064516	0.0441015489555719	0.162165457224936	1	1	0.999999349769181	0.999999349769181	1
up	FN1; ITGB2; INHBA; MMP9; HMGA2; LAMA3; MIXL1;	GO:0035987~endodermal cell differentiation	7	28	25	0.0446165650705942	0.781715889787239	1	1	1	1	1
down	NME1; AK4; AK8;	GO:0006165~nucleoside diphosphate phosphorylation	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	PEX10; PEX11A; PEX11B;	GO:0007031~peroxisome organization	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	POU3F1; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	NFIB; BMP7; SMAD1;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	CTTN; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	CLTA; AP2S1; CLTB;	GO:0048268~clathrin coat assembly	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	DVL1; EPHB3; ZNF365;	GO:0060997~dendritic spine morphogenesis	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	APOE; RHBDF1; NUDT15;	GO:0061136~regulation of proteasomal protein catabolic process	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	AACS; GRAMD1C; SMO;	GO:0071397~cellular response to cholesterol	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	ARF4; EIF6; FOXM1;	GO:2000377~regulation of reactive oxygen species metabolic process	3	18	16.6666666666667	0.0448619238020787	0.162928382509108	1	1	0.999999349769181	0.999999349769181	1
down	SPINT2; FZD6; BMP4; RARG; GRHL2; GRHL3; ST14;	GO:0001843~neural tube closure	7	78	8.97435897435897	0.0450333413142844	0.163308454936604	1	1	0.999999349769181	0.999999349769181	1
down	ANXA1; SCGB1A1; DUOXA1; DUOXA2; MGLL; ACE2; BCL6B;	GO:0050727~regulation of inflammatory response	7	78	8.97435897435897	0.0450333413142844	0.163308454936604	1	1	0.999999349769181	0.999999349769181	1
down	PAX1; FOXF1; FOXC1; MESP2; MESP1;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.0454156340827117	0.164329350541883	1	1	0.999999349769181	0.999999349769181	1
down	MAP2; BMP7; IGSF9; BAIAP2; EGFLAM;	GO:0016358~dendrite development	5	46	10.8695652173913	0.0454156340827117	0.164329350541883	1	1	0.999999349769181	0.999999349769181	1
down	SLC9A3R1; XDH; HYAL2; TRIB3; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	5	46	10.8695652173913	0.0454156340827117	0.164329350541883	1	1	0.999999349769181	0.999999349769181	1
down	ADCY2; GNA14; ADRA2C; GNAI1; ADRA2A; GNA11;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	6	62	9.67741935483871	0.0462625365279145	0.167270013817116	1	1	0.999999349769181	0.999999349769181	1
up	PTPRC; HLA-G; LILRB1;	GO:0001915~negative regulation of T cell mediated cytotoxicity	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	HCLS1; EVI2B; LEF1;	GO:0030854~positive regulation of granulocyte differentiation	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	CD3E; CCL5; SKAP1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	SASH3; TNFSF4; NCKAP1L;	GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	MGAM; AMY2A; CHIT1;	GO:0044245~polysaccharide digestion	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	PTH; SFRP4; FGF23;	GO:0055062~phosphate ion homeostasis	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	ACOD1; CD14; FAM49B;	GO:0071219~cellular response to molecule of bacterial origin	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	IRF4; SLAMF6; LY9;	GO:0072540~T-helper 17 cell lineage commitment	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	IL4; TNFRSF1B; CD200R1;	GO:0150079~negative regulation of neuroinflammatory response	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0470281392144017	0.781715889787239	1	1	1	1	1
up	PGLYRP1; CD1D; PGLYRP2; NLRC4;	GO:0016045~detection of bacterium	4	11	36.3636363636364	0.0480247240837832	0.781715889787239	1	1	1	1	1
up	TLR4; IFNG; TNFSF4; NCKAP1L;	GO:0032700~negative regulation of interleukin-17 production	4	11	36.3636363636364	0.0480247240837832	0.781715889787239	1	1	1	1	1
up	IL2RA; STAT5A; STAT5B; JAK3;	GO:0038110~interleukin-2-mediated signaling pathway	4	11	36.3636363636364	0.0480247240837832	0.781715889787239	1	1	1	1	1
up	IL27RA; BANK1; CD200R1; C5AR2;	GO:1900165~negative regulation of interleukin-6 secretion	4	11	36.3636363636364	0.0480247240837832	0.781715889787239	1	1	1	1	1
up	TLR4; CYBA; CD36; TLR6;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	4	11	36.3636363636364	0.0480247240837832	0.781715889787239	1	1	1	1	1
down	TBX6; BMP7; MESP1; MESP2;	GO:0001707~mesoderm formation	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	BGN; FOXC1; EPAS1; DLL4;	GO:0001974~blood vessel remodeling	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	UQCRC1; MDH2; NDUFS7; UQCRH;	GO:0009060~aerobic respiration	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	PHGDH; SRD5A1; PTN; MPST;	GO:0021510~spinal cord development	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	DNAJB1; HSPA2; HSPE1; HSPA1B;	GO:0051085~chaperone cofactor-dependent protein refolding	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	KREMEN2; KREMEN1; INTU; MED31;	GO:0060173~limb development	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	EGFR; HYAL1; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	4	32	12.5	0.048160964730562	0.172983435728274	1	1	0.999999349769181	0.999999349769181	1
down	LRP5; POLR2I; YAP1; SOX2; POLR2L; HES1;	GO:0035019~somatic stem cell population maintenance	6	63	9.52380952380952	0.0490924103606806	0.176199612240975	1	1	0.999999349769181	0.999999349769181	1
down	PHGDH; APOE; MAP2; CDH1; RAB13; RAB11A; ADGRF1; NRTN; CAMSAP3;	GO:0031175~neuron projection development	9	115	7.82608695652174	0.0498663919620964	0.178846326597196	1	1	0.999999349769181	0.999999349769181	1
